Effects of corn on microRNA expression within horses, The by Carver, Clarissa
THESIS 




Department of Animal Sciences  
 
In partial fulfillment of the requirements 
For the degree of Master of Science 
Colorado State University 
Fort Collins, Colorado 
Spring 2021 
Master’s Committee: 
Advisor: Tanja Hess 


















EFFECTS OF CORN ON MICRORNA EXPRESSION WITHIN HORSES 
 
 
Nutrition has been shown to play a major role in the health of horses in all life stages and levels 
of work. In recent years the prevalence of equine obesity has increased as more horses are kept in 
stalls with lower workloads, while receiving high energy and calorically dense feeds like grain, 
many of which contain corn, in addition to forage. The increase in equine obesity has been 
accompanied by more cases of metabolic diseases developing, often linked to poor nutrition and 
diets high in non-structural carbohydrates (NSC). Although more cases of metabolic disorders 
are emerging there currently are no good biomarkers to diagnose these diseases or identify horses 
on diets providing them with poor nutrition. Diets high in NSCs have been linked to insulin 
resistance and laminitis within horses, two of the main components of Equine Metabolic 
Syndrome (EMS), however nutrigenomic studies looking at the interaction of diets high in NSCs 
on gene expression, specifically through the regulation of endogenous microRNAs (miRNA) are 
rare. Recent research on mice and human models has demonstrated the large impact diet has on 
levels of miRNAs within the body and mRNA targets for these miRNAs resulting in the 
regulation of gene expression, in addition to identifying miRNAs in circulation that can be used 
as biomarkers for obesity, type 2 diabetes, and metabolic syndrome. Research has also 
demonstrated the ability of diet-derived exogenous miRNAs to be absorbed from the digestive 
tract, appear within circulation, and be taken up by various tissues throughout the body. Diet-
derived miRNAs specifically from plants have been detected in tissue and circulating within the 
blood suggesting the possibility of cross-species gene regulation, but the exact role these 
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miRNAs play physiologically is still unknown. miRNAs are small non-coding molecules that 
affect post-transcriptional gene regulation and RNA silencing by translational repression or 
degradation. Previous research revealed that some plant miRNAs could be identified in equine 
serum exosomes and tissues but was not able to identify a corn specific miRNA within any 
equine samples.  
We first hypothesized that diet-derived corn miRNAs can be detected in equine serum 
and muscle after corn supplementation. For this study twelve mares were blocked by weight and 
BCS and assigned to one of two treatments (n=6/group): 1) control, (basal diet: 20 lbs./head/d of 
chopped mixed alfalfa-grass hay and ad libitum mixed grass hay), 2) basal diet supplemented 
with 1 lb./d steam flaked corn. Muscle biopsies of the Gluteus medius and serum samples were 
collected from all horses on d0 and d28. Samples were analyzed using real-time RT-qPCR for 3 
plant miRNAs. Our results revealed the presence of plant miRNAs in equine total serum and 
skeletal muscle. Our results also revealed the level of plant miRNAs, including the corn specific 
miRNA, within circulation vary after ingestion, suggesting plant miRNAs are capable of being 
taken up by equine tissues. These results are important for understanding how physiological 
processes may be impacted by diet-derived plant miRNAs. Moreover, these results suggest plant 
miRNAs could potentially serve a therapeutic role in helping to regulate endogenous gene 
expression in addition to the nutrients being provided by ingestion. The large impact diet can 
have on equine health and the association between diets high in NSC and insulin resistance, 
caused us to be interested in the effects a diet supplemented with corn would have on 
endogenous miRNAs within the horse. We hypothesized that supplementing horses with corn 
would alter the endogenous miRNA profiles within both serum and skeletal muscle. For this 
objective, we utilized the same serum and muscle samples collected for the feed trial horses as 
iv 
the plant miRNAs. Samples were analyzed using real-time RT-qPCR for 277 endogenous equine 
miRNAs. Our results showed 13 differentially expressed (P<.05) miRNAs in equine serum after 
28 days of corn supplementation. Six of these miRNAs (eca-mir16, -4863p, -4865p, -126-3p, -
296, and -192), were linked to obesity and/or metabolic disease. Within skeletal muscle, our 
results showed three miRNAs differentially expressed (P<.05) and three miRNAs with a trend 
toward differential expression (.05<P<.1) after 28 days of corn supplementation. The differently 
expressed (P<.05) miRNAs in muscle (eca-mir1515p, eca-mir106b, and eca-mir133a)  were all 
associated with obesity or muscle insulin response, while two of the miRNAs with a trend 
towards differential expression (.05<P<.1), ecamir-10b and eca-mir129a5p, were associated with 
diabetes/hyperglycemia and glucose metabolism respectively. This data indicates that diet does 
influence levels of endogenous miRNAs.  
The results of our study indicate that diet-derived plant miRNAs can appear in 
circulation, be taken up into tissues, and hold the potential to regulate endogenous genes. This 
study also provides more information on how a diet high in NSCs, like diets containing corn, 
alters levels of endogenous miRNAs within serum and tissue and helps to better understand the 
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The diet and feeding behaviors of horses today are dramatically different from those of 
their ancestors and tailored to human convenience, not physiologic make-up. Research has 
shown that equine performance is heavily influenced by many factors including genetics, 
nutrition, metabolism, exercise, and stress. The smaller two region stomach and lack of gall 
bladder in the equine make them more suited physiologically to periodic grazing throughout the 
day than the typical two concentrated meals per day that are implemented at most equine 
facilities. Many equine rations contain energy supplements like corn, which is a high energy feed 
and low cost to provide horses with the energy necessary to meet performance expectations. 
Corn contains starch, a highly fermentable carbohydrate, which is known to contribute to 
laminitis. Corn and other non-structural carbohydrates have been linked to a variety of metabolic 
issues including laminitis, insulin resistance, and obesity (Pollitt and Visser, 2010). These 
metabolic issues when displayed together may indicate the horse has Equine Metabolic 
Syndrome (EMS), a similar condition to diabetes mellitus type 2 in humans. These issues and 
conditions are not yet fully understood and investigations into the dietary role in the regulation 
and expression of genes are being conducted, as well as attempting to identify reliable markers to 
use in the diagnosis of these conditions. The role of small RNA molecules called microRNAs 
(miRNAs) in gene regulation and as disease markers are subject to recent and current research 
(Nulton, 2014; Santos et al., 2018), as well as the presence of plant-derived miRNAs in 
mammalian serum (Zhang et al., 2012).  
MicroRNAs are small non-coding molecules about 22 nucleotides in length that affect 
post-transcriptional gene regulation and RNA silencing found circulating freely in blood or 
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within micro-vesicles (Zhang et al., 2012). The miRNAs are partially complementary to a few 
target mRNAs which they inactivate (Zaiou et al.,2018). Nearly all cell functions are thought to 
have miRNAs involved in their regulation, with miRNAs circulating in the blood thought to have 
a large role in the regulation of cells from a distance and cell communication. Interest in 
miRNAs and their roles within diseases and cellular processes has led to increased research in 
both healthy and diseased individuals in many species (Garcia-Elias et al., 2017). Recent studies 
have found a connection between specific miRNAs in humans and higher rates of obesity and 
metabolic diseases like type 2 diabetes. Some miRNAs in horses have also been linked to 
metabolic disease, obesity, and insulin resistance (Santos et al., 2018). The trend of increasing 
metabolic issues within horses can be linked to the shift in their diets from the natural 16 hours a 
day of grazing to two meals a day with increased non-structural carbohydrate (NSC) content. 
This study is one of the first to investigate the impact of diet on the profiles of 
endogenous miRNA levels and the presence of diet-derived exogenous plant miRNAs in horses. 
This study will add to the body of work within other mammals investigating the idea that 
miRNAs can be taken up from the diet and how diet impacts miRNAs in different species. 
Specifically, the effects of a corn supplemented diet on endogenous miRNA levels compared to a 
control diet (grass and alfalfa only) will be examined. 
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MiRNAs are short non-coding RNAs ranging from 18-25 nucleotides in length 
responsible for inhibiting translation and degrading mRNAs by binding to the 3’ untranslated 
regions, coding sequences, or 5’ untranslated regions (Alemida et al.,2011). A large portion of 
the human genome is affected by miRNAs illustrating their large impact upon gene regulation 
within the body (Garcia et al, 2017). Many biological functions are influenced by miRNA 
regulated genes. The first miRNA identified was lin-4 located within the genes controlling larval 
stages in the nematode Caenorhabditis elegans in 1993. The second miRNA to be discovered, 
let-7, was found in 2000 and contributes to larval stage regulation in nematodes as well (Alemida 
et al., 2011). The discovery of let-7 and its conservation across species led to thousands more 
miRNAs being discovered in a variety of different species and the identification of more 
universally conserved miRNAs. The miRNA functions within plants and animals have been 
found to slightly differ. Plant miRNAs affect RNA cleavage and degradation while animal 
miRNAs inhibit translation and alter transcription (Taylor et al., 2014). In addition to their gene 
silencing activity, miRNAs have also been found to interfere with regulatory proteins through 
decoy activity. Decoy activity is when a miRNA binds to a region, instead of the normal gene, an 
example being when miR-328  was found to independently bind to the non-seed region of 
hnRNP E2 and prevented the binding of CEBPA with the protein (Alemida et al., 2011). The 
specific function of many miRNAs has yet to be discovered and new research continues to 





MiRNA coding genes most frequently occur within the introns or intergenic regions of 
protein-coding genes. Intergenic regions are located in between genes, while introns are located 
within a gene and removed before protein assembly. For mammalian miRNAs, the miRNA 
coding gene is transcribed by RNA polymerase II (Lee et al, 2004) or in some cases RNA 
polymerase III (Gu et al, 2010). RNA polymerase II is the catalytic portion of the enzyme 
complex responsible for transcribing DNA in mRNA (Cramer, 2004), suggesting miRNA is an 
essential regulatory component for normal cellular function and can be derived from loci 
throughout the genome. Within the nucleus creating primary miRNAs (pri-miRNAs). Pri-
miRNAs have a 5’ cap and poly-adenylated 3’ and are converted by RNAse III Drosha and 
Pasha proteins within the nucleus to pre-miRNA (pre-miRNA) which are 60-100 nucleotides in 
length. The pre-miRNA is then transported into the cytoplasm by an exportin-5 dependent Ran 
protein and converted by the Dicer-1 enzyme and PACT proteins into a double-stranded miRNA 
duplex that is shorter in length than the pre-miRNA. The duplex is then unwound by helicase 
into a single-stranded mature miRNA ranging from 15-22 nucleotides in length. One strand of 
miRNA is degraded, while the other strand is incorporated into an Argonaute (AGO) protein 
complex to create the miRNA-induced silencing complex (miRISC), which acts as a mediator for 
gene silencing (Alemida et al., 2011). The biogenesis of mammalian miRNAs is illustrated in 
Figure 1. Some miRNAs contain additional sequences that control their location within the cell 
of the animal, for example, miR-29b contains an extra six nucleotide terminal motif that directs it 
back into the nucleus after formation and maturation (Hwang et al., 2007).  
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Figure 1: mammalian microRNA synthesis and mechanism of gene regulation.1. MicroRNAs are transcribed by 
RNA polymerase III (not shown in the figure) and form pri-miRNAs, one form of RNA precursors. 2.Pri-miRNAs 
are processed in the nucleus by Drosha and DGCR8, resulting in pre-miRNAs. 3. Pre-miRNAs are transported into 
the cytoplasm via exportin-5. 4. Once in the cytoplasm, Dicer continues to process the pre-miRNA forming a 
miRNA duplex with two complementary short miRNA sequences. 5. Helicase breaks apart the miRNA duplex into 
individual molecules. 6. One miRNA sequence is integrated into the RISC complex via an AGO protein (not 
pictured), while the other strand is degraded. 7. At this point, miRNAs can exert their regulatory effects on 
messenger RNAs (mRNAs) via mRNA cleavage or translational repression. Adapted from: Saif and Emanueli, 
2014. 
The biogenesis of plant miRNAs is very similar to that of mammalian miRNAs, but a few 
different plant enzymes are utilized within the process in place of their mammalian counterparts 
(Figure 2). miRNA coding genes are translated to pri-miRNAs within the nucleus by RNA 
polymerase II. The pri-miRNAs are then converted to pre-miRNAs through interactions with 
DCL1 (dicer-like 1), dsRNA-binding protein 1 (dRB1), and Hyponastic leaves1 (HYL1) which 
cleaves the RNA. The pre-miRNA is acted on a second time by DCL1 and HYL1 to form the 
mature miRNA duplex within the nucleus still. Before exiting the nucleus, the mature plant 









giving the mature plant miRNA the defining characteristic of a 2’-O-Me modification on 3’ end. 
The mature methylated miRNA is then transported into the cytoplasm by HASTY, the plant 
ortholog to Exportin-5. Within the cytoplasm plant miRNAs, like mammalian miRNAs, 
combines with an AGO protein (AGO1) to form the miRISC, however unlike mammalian 
miRNAs plant miRNAs need ATP and Hsc70/Hsp90 to help with the formation of the miRISC 
(Iwasaki et al., 2010; Nakanishi, 2016). 
 
 
Figure 2: The biogenesis of Plant miRNAs. Plant pri-miRNAs are produced from MIR genes by RNA polymerase II 
(Pol II). Pri-miRNAs are cleaved into pre-miRNAs by DCL1, DRB1, and HYL1. Pre-miRNAs are cleaved into miRNA 
duplexes by DCL1 and HEN1. MiRNA duplexes are methylated by HEN1 into mature miRNA duplexes and are 
exported to the cytoplasm through the action of HASTY. One strand is then degraded and the other is then loaded 
onto an AGO protein with the help of Hsc70/Hsp90  and ATP, to form a miRISC which influences gene silencing.  
Original Source: Liu, S. et al., 2017 
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MiRNA modes of action 
 
MiRNAs are a central component of RNA interference, a biologic process within which a 
targeted mRNA is silenced by an RNA molecule resulting in the inhibition of translation or gene 
expression. RNA interference begins when the Dicer enzyme cleaves the pre-miRNAs into 
miRNA duplexes before helicase breaks the duplex into 2 separate RNA sequences. One of the 
sequences degrades while the other miRNA sequences bind to an RNA-induced silencing 
complex (RISC), to form the miRISC complex that is ultimately responsible for the destruction 
of the target mRNA resulting in gene silencing (Sontheimer, 2005). The exact mechanism to 
achieve gene silencing differs between plant and mammalian miRNAs. Mammalian miRNAs 
target the untranslated regions of mRNAs and bind to the target region with the standard base 
pair matching conventions. The mechanism of gene silencing is determined by the degree and 
nature of complementary nucleotides within the target region compared to the miRNA. Cleavage 
of the target region by Ago2 endonucleases requires extensive near-perfect matches of base 
pairs, in contrast, translational inhibition requires multiple sites of complementary sequences 
with minimal base-pairing in each site; Hence, why translational inhibition is the more common 
mode of gene silencing for mammalian miRNAs (Bartel 2004, Yekta et al., 2004). Within 
mammals, the entire miRNA may not match the target mRNA completely resulting in RNA 
hybrids that contain bulges that alter the specificity and could impact the gene silencing ability of 
the miRNA (Brennecke et al., 2005). Plant miRNAs achieve gene silencing mainly through the 
process of mRNA cleavage, however, they can also do translation inhibition (Broderson et. al, 
2008). Plant miRNAs unlike mammalian miRNAs target the coding regions of mRNAs and 
cleave them apart. As a result of cleaving the mRNA apart, it decays, an irreversible process, 
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while translational inhibition can be reversed.  It is generally accepted that multiple miRNAs can 
bind to the same targets on genes and miRNAs can have multiple targets they can influence. This 
means that plant and mammalian miRNAs could potentially target some of the same genes 
resulting in silencing of the same gene, highlighting the importance of understanding where 





The majority of identified miRNAs have been found within cells, but the presence of 
miRNAs outside of the cellular environment has also been well identified (Zhu et al, 2011, 
Lechhi et al, 2017). The ability of miRNAs to enter the extracellular environment and contribute 
to cell-to-cell communication occurs through secretion through five different mechanisms: 
microvesicles, exosomes, apoptotic bodies, high-density lipoproteins (HDL), or Ago protein 
complexes (Makarova et al., 2016, Sohel, 2016). Microvesicles are formed through the direct 
process of budding off the plasma membrane and fission of the two sides to encapsulate the 
contents now in the extracellular environment, they can be differentiated from exosome by 
surface markers and size (Lee et. al, 2012). Exosome also involves budding to transport their 
contents from the inside of the cell to the outside, however, they are completely formed within 
the cell by invagination of the cell wall and must receive a signal to bud off into the extracellular 
environment (Johnstone, 2006). Another potential method of transporting miRNA in the 
extracellular environment are apoptotic bodies, which are the largest of the possible methods and 
are a result of cell death via apoptosis. Apoptotic bodies are formed towards the end of the 
process of apoptosis and can contain a variety of nucleic acids in addition to miRNAs, the exact 
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impact and mechanism of miRNAs carried by apoptotic bodies are not currently known and 
future research is needed to better determine how much of a role this particular method of 
transportation impact cell to cell communication (Soehl, 2016). HDL is usually associated with 
the digestive and metabolic process, but its high affinity for water-insoluble compounds makes it 
capable of attracting and carrying miRNAs throughout the body and facilitate communication 
between cells all over the body. Unlike microvesicles, exosomes, and apoptotic bodies purified 
HDLs only contain small non-coding RNAs (Vickers et al., 2011). The fifth method potentially 
responsible for extracellular miRNAs has already been mentioned as AGO protein complexes 
form RISC complexes with miRNA, AGO2 is part of the RISC and has been found with miRNA 
in cell culture media (Turchinovich et al., 2011). A study by Arroyo et al. demonstrates that only 
about 10% of cell-free miRNA within human plasma was released through microvesicles, with 
potentially up to 90% of the cell-free miRNA found within circulation we found to co-fraction, 
using size-specific chromatography, with ribonucleo-protein complexes like the AGO family 
(Arroyo et al., 2011).  Looking at studies identifying the presence of extracellular miRNAs the 
sample type, method of extraction, quantification tests, and normalization procedures all seem to 
impact the ability to identify miRNAs within the extracellular environment, making it currently 
challenging to definitively identify which of the five potential methods has the most impact upon 
cell-to-cell communication and gene regulation.  
 
UPTAKE OF DIETARY MIRNA 
 
The uptake of miRNAs from the diet is not currently fully understood and is highly 
debated. The first studies to show the possibility of diet-derived miRNAs were conducted with 
rice, a common and staple food throughout the world. Many studies have found evidence of diet-
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derived plant miRNAs within mammals, however, many contradicting studies were not able to 
find plant miRNAs within mammals, with the reliability of detection and biologically significant 
levels being the largest issues. The low repeatability of identifying dietary miRNAs in circulation 
may be due to the short window of detectability, because of their rapid clearance and degradation 
by nucleases. When miRNAs were directly injected into the vein, they were completely cleared 
from circulation within three hours (Yang et al., 2015). The detection of miRNAs within 
circulation suggests nuclease resistant forms of miRNA exist and remain in circulation for longer 
periods than those that are not resistant (Yang et al. 2016). 
MiR2911 is found within plants and was found in increased levels in the circulation of 
mice fed diets containing various plants (Yang et al., 2015; Yang et al., 2016). Mice receiving 
feed with ground honeysuckle had miR2911 expression 39-fold higher at the end of a seven-day 
feeding trial compared with before the trial (Yang et al., 2015). This miRNA was also found to 
be the most stable during digestion when compared to miR168, a plant miRNA that has also 
been found in circulation (Zhang et al., 2012), and an artificial mRNA (Yang et al.,2016). In 
contrast, corn specific miRNA was not found in circulation when fed to mice with a water 
gavage, likely uptake into circulation may be inhibited by excessive and early degradation during 
the process of digestion (Huang et al., 2018). Corn specific miRNA was also not found in equine 
circulation six hours after consuming 1 pound of corn, however, a common plant miRNA, miR 
156a, was identified within serum exosomes at this time point as well as within the tissues 
(Nulton, 2014). Exosomes are endosome derived extracellular lipid-membrane bound vesicles 
that transport proteins and RNAs between cells. One theory of how miRNAs from food exit the 
lumen of the intestines and into other systems within the body involves the miRNA being 
encapsulated by nutrient particles from the food which are then absorbed into the lymphatic and 
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circulatory systems through the digestion process (Chan and Snow, 2017). This theory also states 
that potentially miRNA from the diet gets from the lumen of the gastrointestinal tract into 
circulation and subsequently various tissues by being packaged within exosomes or 
ribonucleoprotein (RNP) complexes, like HDL. Once packaged the RNP complexes or exosomes 
cross the epithelium by transcellular transportation, paracellular transportation, or immune 
conveyance mechanisms. Once through the barrier, they can go into the circulatory system, 
lymphatics system, or nearby connective tissue cells. Within the circulatory system, the 
exosomes and/or the RNP complexes are carried throughout the body for possible uptake by a 
wide variety of tissues (Chan and Snow, 2017). This process is illustrated in Figure 3. 
 
Figure 3: Diagram of a possible method of Dietary miRNA uptake from the digestive tract. To potentially 
impact gene expression within a mammal the miRNAs from the diet must be absorbed from the digestive tract into 
circulation or intestinal tissues. A) miRNAs from the diet ( potentially packed in 1) RNP complexes or 2) within a  
vesicle)  cross the epithelial barrier (white cells) via transcellular, paracellular, or immune cell conveyance (gray). 
Once through the epithelial barrier, the miRNAs are likely taken up by stromal cells (brown), neighboring cells, 
lymph systems (light grey) or enter the circulatory system (red). B) once in the circulatory system the miRNAs 
could exit via many mechanisms to a wide variety of cells, tissues, and organs. The molecular level of this process 
warrants more studies to develop a better understanding. Original Source: Chan and Snow, 2017. 
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Transcellular pathways through the epithelium involve the exosome binding to the cell 
membrane or transported whole into the cell via protein transporters before passing through the 
cytoplasm and being transported to the outside of the cell on the other side. Paracellular 
transportation involves the exosome or RNP complex to pass between the junctions between the 
epithelial cells. In a normal healthy individual, there should be tight junctions between the 
intestinal epithelial cells. The presence of tight junctions in a healthy individual would make 
paracellular transport unlikely, however, in an individual that has compromised epithelium 
within their intestines, these tight junctions may be weakened allowing paracellular transport to 
occur. Within humans the epithelial barrier begins to lose its function with age and allows for 
some paracellular transport, this can also potentially occur with inflammation, toxins, and 
infection (Chan and Snow, 2017). Horses also can have a breakdown in the integrity of their 
intestinal epithelium allowing for paracellular transport. This equine condition has also been 
termed ‘leaky gut’ as it has been in humans. Within horses, the breakdown of this barrier can be 
attributed to a variety of causes including stress, ischemic reperfusion injuries (as would occur 
after a colon torsion), pathogens, inflammatory bowel disease, microbiota, and nutrition. Within 
horses, the nutritional component most often believed to cause damage to the epithelium is an 
overabundance of starch which can lead to acidosis which damages the intestinal lining ( Stewart 
et al., 2017). This potential for more uptake in individuals with compromised epithelial barrier 
could explain why there is so much variation in the detection of miRNA uptake by individuals. 
The surface of the intestines is composed of more than just epithelial cells, there are also 
immune cells integrated within the surface that could also play a potential role in the uptake of 
miRNA from within the lumen. Immune cells that populate the surface of the intestines include 
M cells, B cells, T cells, macrophages, and dendritic cells (Peterson and Artis, 2014). Some plant 
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nanoparticles have been identified that target intestinal macrophages, but they do not appear to 
be dependent upon miRNAs and no data shows the delivery of miRNAs to other cells via 
immune cell delivery( Mu et al., 2014).  
Within mammals the possibility of miRNAs crossing the intestinal epithelium and 
becoming widely spread throughout the body is complicated and would likely require multiple 
rounds of ingestion, crossing the intestinal barrier, and uptake by cells to even hold the 
possibility of reaching distant tissues. This brings in to question the frequency and dosage of 
miRNAs within the food that would be needed to achieve systemic spread and uptake of these 
dietary miRNAs (Chan and Snow, 2017). Although there are many theories the exact 
mechanisms involved in the uptake of exogenous miRNA into mammalian circulation still need 
further exploration as current studies contradict each other and the mechanisms involved in 
miRNA absorption are still not fully understood.  
 
miRNA ROLE IN DISEASE 
 
The role of miRNA in disease has been an increasingly popular area of research since its 
discovery and categorization. The level of expression of certain miRNAs has been found to 
differ in diseased mammals versus healthy mammals. The use of miRNAs as biomarkers has 
largely been within patients suffering from a wide variety of cancers, viral infections, nervous 
system disorders, cardiovascular diseases, and metabolic diseases. Specific miRNA changes 
have been found for large B-cell lymphoma, lung cancer, breast cancer, liver cancer, pancreatic 
cancer, ovarian cancer, and prostate cancer (Wang et al., 2015). Due to the increased occurrence 
of human metabolic diseases like diabetes, research has been done to identify miRNAs that can 
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be used as biomarkers for the disease and their role as regulators of metabolic functions (Wang et 
al., 2015). These studies have identified many miRNAs that contribute to human metabolic 




 Obesity and being overweight occur when an individual has a high percentage of their 
body composed of fat. Obesity is a complex metabolic disorder characterized by an excessive 
accumulation of fat in various body parts (Khan et al., 2015). Within horses, fat tends to 
accumulate along the crest of the neck, the withers, the loin, the tailhead, behind the shoulders, 
and over the ribs (Figure 4), or generally distributed where abnormal amounts of fat can be found 
all over the body.  Within horses using the Henneke body condition scoring system a score of 6-7 
is considered overweight and 8-9 is considered obese, description of each score within this 
scoring system can be found in Appendix Table IV. Fat is made up of adipose tissue and is not 
just an energy-storing tissue, it also releases adipokines which help to regulate immune function, 
energy metabolism, reproductive status, and cardiovascular function. The most well-known and 
studied adipokines are leptin, adiponectin, angiotensin, and more recently resistin (Radin et al. 
2009). Leptin is released from white adipose tissue and acts on the hypothalamus, which contains 
multiple nuclei responsible for regulating appetite and metabolism. 
When an animal has an increase in fat mass, like in the case of an animal becoming 
obese, dysregulation in the production of adipokines occurs resulting in diseases within patients. 
Recent studies have begun to identify miRNAs linked to the promotion and inhibition of 
adipogenesis and the development of obesity, and obesity-related diseases, which could also 
have impacts upon adipokines (Zaiou et al., 2018). Support for miRNA’s role in adipogenesis 
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came from studies showing that adipogenesis was altered when the DICER enzyme, which is a 
key factor in miRNA generation, was knocked out and decreased fatty acids were present within 
the body (Mudhasani, et al., 2010). Additionally, miRNAs circulating within the body have been 
found to change in patients with diseases like type 2 diabetes mellitus (T2DM), hypertension, 
hepatic injury, and atherosclerosis (Rottiers and Narr, 2012).  Type 2 diabetes mellitus is a 
metabolic condition in humans, dogs, and cats most commonly believed to be caused by insulin 
resistance with the majority of individuals with this disease being classified as obese or on the 
top end of overweight. The Let-7 family of miRNAs has been shown to regulate glucose 
metabolism in a variety of different organs, mice in which Let-7 was knocked down showed 
increased glucose tolerance and a reduction of fat mass (Frost and Olson, 2011). Within horse 
the reports of true cases of Diabetes mellitus are rare, but Equine Metabolic Syndrome (EMS) 
has many similar factors involved within it.  EMS is most often associated with obesity, insulin 
dysregulation, and laminitis signs similar to how T2DM can manifest in humans who are often 
obese, insulin-resistant, and can develop neuropathies in lower extremities if left unmanaged. 
There are currently no miRNAs within horses identified for use as biomarkers of EMS. Most 
Horses with EMS often are classified as obese, but the most consistent and important feature of 
EMS is insulin dysregulation, with laminitis being the consequence of horses with clinical EMS. 
The trend for horses with EMS also being obese is likely due to the decreased production of 
adiponectin which is associated with insulin sensitivity and a reduction in inflammation, making 
it inversely related to obesity and insulin resistance. (Durham et al., 2019). The reduction in 
adiponectin in obese individuals allows for a chronic state of low-grade inflammation to persist 




Figure 4: Areas of evaluation when body conditioning horses with the Henneke system. When body condition 
scoring a horse area of interest for fat deposition are along the neck, withers, ribs, tailhead, behind the shoulder, and 
if a crease is formed down the back. Each area should be evaluated and scored to accurately give the horse’s overall 




Insulin resistance (IR) is a state of reduced responsiveness of tissues to insulin, regardless 
of if it is at normal or elevated levels within the blood; this mainly affects hepatic, skeletal 
muscle, and adipose cells within tissues (Bhattacharya et al. 2007, Frank and Tadros 2013). 
Insulin resistance is an area of special interest within horses as it not only plays an important role 
in EMS but also has been associated with the development of laminitis in horses (Bertin and de 
Laat, 2017).  In the early stages of insulin resistance, the beta cells of the pancreas compensate 
by producing more insulin to minimize the period during which blood glucose levels are 
elevated. As the condition continues the insulin receptors in the tissue become more desensitized 
to insulin and the pancreas continues to produce waves of insulin to produce a strong enough 
signal to bring glucose concentration down to basal levels.  There are a few mechanisms that 
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have been identified as contributing to the tissue insulin receptor. The first is pre-receptor 
abnormalities resulting in reduced insulin concentration or receptors for the tissue of interest. 
The second and more common one is for abnormalities in signal transduction to occur which 
results in IR. The abnormal signal transduction could be attributed to reduced tyrosine-kinase 
activity and reduced receptor phosphorylation which then causes a reduction in the 
phosphorylation of insulin receptor substrate-1 and decreased phosphatidylinositol 3-kinase 
activity. The third mechanism is abnormalities in the metabolism of glucose within cells, 
regulated by hexokinase and glycogen synthetase, which could be reduced by insulin-dependent 
uptake of glucose and its subsequent storage (Treiber et al., 2006). Hyperinsulinemia occurs 
when there is too much insulin within circulation for the amount of stimulus the body received 
and can occur intermittently or persistently (Frank and Tadros, 2013). Hyperinsulinemia doesn’t 
only occur as a result of tissue insulin resistance it can also happen for other physiological 
reasons like an exaggerated response to a meal containing carbohydrates resulting in transient 
hyperinsulinemia with no insulin-resistant tissue present (de Laat, McGree, and Sillence, 2016).  
When healthy horses were infused within insulin to create a hyperinsulinemia state some 
individuals did develop laminitis (Asplin et al., 2007) illustrating a link between laminitis and 
hyperinsulinemia. This suggests that insulin resistance and hyperinsulinemia could separately 
contribute to the development of laminitis in horses, rather than both factors needing to be 
present. Laminitis is a painful condition and can have a serious impact on a horse’s quality of 
life, there are currently no consistently effective ways to treat laminitis making prevention the 
best option for many horses, especially horses with EMS. Many different tests can be done to 
diagnose a horse with insulin resistance or hyperinsulinemia including fasting glucose tests, the 
euglycemic hyperinsulinemic clamp test, insulin sensitivity test, or the frequently sampled 
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intravenous glucose test (Bertin and de Laat, 2017), however many of these tests are time-
consuming and expensive minimizing their useful impact to the industry as a whole. The 
development of an economical test that could identify insulin-resistant horses before they 
develop EMS or develop laminitis there would be a large impact on the equine industry and 
general equine welfare. 
The profile of miRNAs endogenous to horses has recently been looked at to determine if 
they differ between horses that are insulin resistant and horses that are considered insulin 
sensitive or normal. Insulin resistant horses were found to have lower levels of five miRNAs 
(esa-mir-147b, esa-mir-370, esa-mir-376c, esa-mir-139- 5p, and esa-mir-1839), higher levels of 
three miRNAs (esa-mir-129a-5p, esa-mir-770, and esa-mir-140-3p) and lacking six miRNAs 
compared to the insulin-sensitive horses (Santos et al., 2018). The mir-376 family has been 
shown to have implications on the regulation of pancreatic beta-cells, cell growth, and could 
potentially serve as a predictive biomarker for obesity. Specifically, mir-376c has been found to 
lack expression in the pancreatic islets of rats with type 2 diabetes (Santos et al.,2018). More 
studies within horses should be conducted to confirm the potential biomarkers. 
Laminitis 
 
Equine laminitis can be caused by a wide range of events, most commonly the ingestion 
of a large amount of NSC within a short period. This large dose of NSC is usually through the 
ingestion of large quantities of grain or fresh grass. During the digestion of these feeds, dysbiosis 
occurs resulting in the release of toxins that weaken the laminae of the hoof and cause 
inflammation (Pollitt and Visser, 2010). In recent years the effect of long-term obesity on the 
incidence of laminitis has also been explored, in addition to miRNA biomarkers for this 
condition. Horses that are obese are in a chronic state of inflammation and have higher 
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mechanical loads for the laminae to support. This leads to the inflammation and weakening of 
the laminae over time from the strain of supporting the extra weight, in addition to hormonal 
changes that occur. Feeding horses NSC at low levels for a long period does not have the same 
detrimental effects as episodes of high NSC intake, such as grain overload, however, more 
research needs to be done to indicate if a diet with NSC at a low level alters the metabolism of 
circulating miRNAs associated with laminitis. Three miRNAs have been found to be expressed 
in different levels in animals displaying acute laminitis, with levels of miR-23b-3p, miR-145-5p, 
and miR-200b-3p being significantly higher in affected horses (Lecchi et al., 2017). The 
accuracy of the diagnosis of acute laminitis using the miRNA profile of horses was found to be a 
good indicator of acute laminitis and positively correlated with the composite pain scale and 
horse grimace scale that have been used to determine the severity of lameness. Although the 
grimace scale is a good indicator of pain, it is not completely reliable as a diagnostic tool as it 
becomes unreliable when looking at stills from videos or photos with no context of 
environmental factors that could be affecting the horse’s expression (Lecchi et al., 2017). Using 
miRNA as biomarkers for diseases in mammals is increasing in use as more studies identify 
miRNA expression linked to disease. 
 
DIETARY REGULATION OF ENDOGENOUS miRNA 
Diet has a huge impact on how mammalian systems function, with many studies about 
the impact of different foods and quantities on health being conducted, including on how diet 
impacts miRNAs. Nutrients and micronutrients within diet have been linked to modifications in 
miRNA profiles within mammals (Garcia-Segura et al., 2013). Diets deficient in amino acids 
have been found to produce proteins that compete with miRNAs for binding sites, altering the 
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regulatory abilities of miRNAs without the levels of miRNA changing (Bhattacharyya et al., 
2006). Amino acids can also cause an increase in miRNA expression, Drummond et al. found 
that after administering a mix of essential amino acids to human subjects there was an increase in 
levels of miR-1, -23a, -208b, and -499 within skeletal muscle biopsies (Drummond et al., 2009). 
The presence of some fatty acids within the diet has been found to alter miRNA expression. 
Diets supplemented with butyrate, a short-chain fatty acid produced by bacteria in mammalian 
colons, resulted in the upregulation of miR-10a and miR-24 which can target the HOXA1 and 
Notch1 genes, ultimately affecting the differentiation of cells (Tzur et al., 2008). Fish oil when 
added to the diet has been found to upregulate tumor-suppressing miRNAs within intestinal cells, 
as well as effect steam-cell regulatory pathways through changes in steady level miRNAs (Cui et 
al., 2017, Davidson et al., 2009). High-fat diets have also been found to increase miR-143 and -
145 in mice, the increase in miR143 resulted in increased fasting plasma insulin levels, impaired 
glucose, and insulin tolerance (Jordan et al., 2011). The nutritional status of pregnant animals is 
believed to have a tremendous impact on the likelihood of offspring developing metabolic 
diseases. Adult offspring of female mice fed a high-fat diet before conception showed reduced 
levels of let-7a, let7b, let7-c, miR-26a, -122, -192, -194, -483, -494-, and -709 during their 
pregnancy and lactation, in addition to increased expression in the liver of insulin-like growth 
factor-2 (Igf2), these findings indicate that epigenetic mechanisms may be involved in the 
maintenance of diet-induced gene expression being maintained into adulthood (Zhang et al. 
2009). The let-7 miRNA family regulates glucose metabolism in multiple organs (Frost and 
Olson, 2011), while miR-122 is a key regulator in cholesterol and fatty acid metabolism (Esau et 
al., 2006). The long-term impacts of gestational nutrition on offspring and miRNAs within the 
body still requires more research.  Carbohydrates within the diet are a major source of glucose 
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for many mammals, glucose level within the body has been identified as a factor influencing 
miRNA expression (Garcia-Segura et al., 2013). Hyperglycemia within mice increased 
expression of miR21 in the kidneys of type 1 diabetics mice and resulted in decreased expression 
of renal proteins responsible for suppressing tumors that result in diabetic nephropathy (Dey et 
al., 2011). On the other end of the spectrum, glucose depletion in mice has been shown to induce 
the production of miR-466h-5p, which plays a role in regulating myocardial hypertrophy, as a 
result of oxidative stress and the inhibition of histone deacetylation (Druz et al., 2012). 
Micronutrients including vitamins, vitamin derivatives, and phytochemicals have also been 
linked to changes in miRNAs levels (Garcia-Segura et al., 2013, Cui et al., 2017). Continued 
research into the effects of diet on miRNA expression could result in a better understanding of 
metabolic diseases and identify miRNA candidates for therapies of these conditions. 
Diet has been found to affect the endogenous miRNA profiles of horses. Nulton found in 
her study horses fed a corn supplemented diet had 37 miRNAs within serum exosomes with 
different levels of expression after 23 days on the diet. Decreased levels in several members of 
the let-7 family (let-7a,c,d, and g), miR-29a, and -143 were found, these miRNAs all relate 
insulin sensitivity and glucose tolerance (Rottiers and Näär, 2012), MiR-27b was also found to 
decrease after supplementation and is also decreased during the process of adipogenesis. In this 
same study three miRNAs linked to adipocyte development (miR 17, -20a, and -20b) and miR-
148, associated with increased insulin biosynthesis, were all found to increase after corn 
supplementation (Nulton,2014). Nulton found miR-20b also increased in horses supplemented 
with rice bran, in addition to an increase in levels of miR-129a-3p which is associated with 
prohibiting cell proliferation (Wu et al., 2010). The rice supplemented horses within Nulton’s 
study showed a decrease in miR-33b which has is associated with the control of fatty acid 
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oxidation and the formation of high-density lipoproteins (Dávalos et al., 2011). To better 
understand the impact of diet on equine miRNA profiles more studies should be conducted, 
perhaps with a wider variety of diets given to horses in different life stages and levels of work. 
DIGESTION 
Horses are considered hindgut fermenters as they are still able to utilize forages like 
ruminants but do not ferment plant matter until after the ingesta has passed through the length of 
the small intestine and into the hindgut. The primary sites for microbial fermentation in horses 
are the cecum and ascending colon. Unlike most monogastric animals, horses have a unique 
structure to their ascending colon, instead of simply traversing one side of the abdomen, the 
ascending colon of a horse doubles over on itself in a horseshoe shape and makes up a larger 
portion of the hindgut than other mammals. The increased volume of both the cecum and 
ascending colon allows microbes within to ferment forages, breaking the beta 1-4 linkages in 
cellulose and producing volatile fatty acids (VFAs) that are used within the body for the 
synthesis of lipids and glucose.  
The first step of digestion for animals is the mechanical reduction of food particles 
through mastication within the oral cavity. Also, within the oral cavity, the initial steps of 
enzymatic digestion will occur due to salivary enzymes before the food bolus is swallowed and 
travels through the esophagus to the stomach (Cheeke and Dierenfeld, 2010). The food bolus is 
moved through the esophagus by waves of muscular contraction called peristalsis. Within the 
equine stomach mechanical, enzymatic, and chemical digestion will occur to break food particles 
down further before the ingesta exits the stomach and enters the small intestine. The small 
intestine, mainly the duodenum, is the primary site of nutrient absorption in mono-gastric 
animals. Enzymes and bile enter the intestinal lumen through the duodenal papillae and continue 
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to break down food particles into absorbable compounds. As previously stated horses are hind-
gut fermenters and break down the cellulose found within plants through microbial fermentation 
within the cecum and ascending colon (Ralston, 2007). The transverse and descending colon of 
the horse mainly functions to absorb water from the ingesta and form fecal balls out of the 
indigestible portion of the feed.  
Carbohydrate digestion and  metabolism 
 
Most rations for horses today use a feed concentrate like corn, barley, or a grain mix to 
provide horses with the energy needed to perform at or above their owner’s standards. These 
feed concentrates contain non-structural carbohydrates (NSC), starches and sugars, and structural 
carbohydrates, cellulose, and lignin (Ralston, 2007). Mammals do not produce enzymes capable 
of breaking down beta1,4 linkages, as a result, they have developed means of microbial 
fermentation to break down these links in structural carbohydrates. As previously mentioned 
within horses this microbial formation happens within the cecum and large intestine and results 
in the production of VFAs which can then be utilized by the body. The production of these VFAs 
can contribute to meeting up to 30% of the horse’s energy needs for maintenance (Glinsky et. al, 
1976). The VFA produced in the largest amount is acetate which is readily usable by the body as 
an energy source, propionate and butyrate are also produced through microbial fermentation. 
Non-structural carbohydrates such as starch are primarily digested in the foregut of the 
horse. As food exits the stomach through the pylorus and into the duodenum a small amount of 
HCl also enters the intestines and triggers the release of pancreatic enzymes, including amylase, 
into the intestinal lumen which breaks down ingested carbohydrates particles until they have all 
been converted to glucose or glycogen. Some starches can be classified as resistant starches and 
pass through the small intestine into the large intestine without being broken down due to the 
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enzymes being unable to properly attach the starches (Englyst and Englyst, 2005).  Glucose is 
then absorbed through the intestinal wall and into the blood to be distributed throughout the body 
to cells in need of glucose. Cells put out insulin receptors when glucose is required and upon 
insulin binding glucose is brought through the cell membrane into the cytosol (Cheeke and 
Dierenfeld, 2010). A marked increase in insulin production occurs after a meal as a breakdown 
of the carbohydrates within the meal causes an increase in blood glucose concentration, requiring 
insulin to push the glucose into cells. Within the cytosol of the cell, glycolysis occurs which 
converts the glucose into pyruvate that can be utilized by the citric acid cycle and electron 
transport chain within the mitochondria to produce ATP. Recent studies have found the ingestion 
of large amounts of carbohydrates can lead to transient hyperinsulinemia  in some horses and 
long-term supplementation of diets high in NSC contribute to increased insulin resistance (de 
Laat, McGree, and Sillence, 2016, Durnham et al., 2019, Treiber et al., 2006) 
Lipid digestion and metabolism 
 
Lipids are an important part of the equine diet as well as integral to the structure of cells 
as cell membranes are made up of phospholipids. When a lipid is ingested the first step to 
breaking down the fat involves lipase enzymes emulsifying the triglyceride into free fatty acids 
and a mono-glyceride, this process starts in the mouth with lingual lipase and continues in the 
duodenal lumen with pancreatic lipase. Due to the hydrophobic nature of lipids they join and are 
surrounded by bile salts to form a micelle. The micelles are then absorbed through the intestinal 
wall into the enterocytes where they have broken down into fatty acids and mono-glycerides 
again (Cheeke and Dierenfeld, 2010). Within the enterocytes, the lipid by-products will either go 
through the mono-glycerol acetyltransferase (MAG) pathway or the Phosphatidic Acid 
Phosphatase (PAP) pathway to reassemble the triglyceride into either a chylomicron or a VLDL 
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(very low-density lipoprotein). The PAP pathway requires glucose to be converted into glycerol 
to use within the process of reassembling the triglyceride, unlike the MAG pathway which 
utilizes the mono-glyceride present within the cell to create triglycerides to put into VLDLs and 
chylomicrons. Once in the lymphatic system VLDLs and chylomicrons become mature and have 
the membrane receptors required to bind to high-density lipoproteins (HDL). After binding to 
HDL, the lipoproteins are transported to adipose tissues with lipoprotein lipase, this results in the 
fatty acids entering the adipose cell where they are reassembled into triglycerides and stored until 
use, while the glycerol backbones are transported to the liver and used in gluconeogenesis.  
Protein digestion and metabolism 
 
Protein metabolism in horses starts within the stomach where hydrochloric acid and 
pepsin denature the proteins through hydrolysis starting at the N-terminal. Pepsin is the activated 
form of pepsinogen which is secreted by chief cells within the mucosal layer of the stomach. As 
polypeptides enter the small intestine secretin and cholecystokinin are released. The proteases 
trypsin, chymotrypsin, and carboxypeptidase are also released into the small intestine from the 
pancreatic duct and further digest the proteins until they are individual amino acids. The amino 
acids are absorbed by the intestinal epithelial cells and released into circulation (Cheeke and 
Dierenfeld, 2010). The amino acids travel through the hepatic portal vein where the liver extracts 
any needed amino acids before the blood is pumped throughout the body to be used in protein 
synthesis, converted to fat, or used within the citric acid cycle in the form of acetyl CoA.  
CONCLUSION 
 
 The targets and impacts of miRNAs on various genes continue to be an area of research 
as we try to understand what roles they play in the everyday functioning of plants and animals, 
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identify new biomarkers, and investigate their ability to be used as a therapeutic agent. Early 
miRNA research largely focused on the role miRNAs play in cancers, tumors, and diseases 
afflicting humans, often using mouse models. Many conditions experienced by humans can be 
modeled within or are found within companion animals, making research into miRNAs profiles 
within animals like horses and dogs in addition to the normal animals used in studies like mice 
and pigs important in the development of information that can be used for translational medicine 
purposes. To better determine if the uptake of diet-derived miRNAs is truly possible more 
research needs to be conducted looking at the stability of miRNAs in the digestive tract and the 
exact method of miRNA transport from the intestinal lumen into circulation, this could also help 
to create ways of using oral supplementation of encapsulated miRNAs as a therapy for a variety 
of diseases. Diet is known to have a large impact on the overall health of animals and diets high 
in NSC have been associated with a higher incidence of insulin resistance within horses 
(Durnham et al., 2019). miRNAs hold a large potential to act as biomarkers for a variety of 
diseases and the creation of more economical tests for diagnosis of diseases and early detection 
of at-risk individuals to allow for appropriate preventive measures to be taken.  
 The equine industry has seen an increase in obesity as more horses are kept in stalls with 
lower activity levels, but many still receive some sort of concentrated feed. Many commercial 
grain mixes fed to horses contain corn, as it is a cheap form of concentrated energy. Corn has a 
large amount of NSC which has been linked to the development of insulin resistance (Durham et 
al., 2019). Recent studies within horses have identified miRNAs within horses that could be used 
as biomarkers for insulin resistance in horses (Santos et al., 2018). Based upon the evidence for 
diet affecting endogenous miRNA profiles within animals and the ability for diet-derived 
exogenous miRNAs to be taken up into circulation, we hypothesized that supplementing corn to 
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horses would result in the uptake of a corn specific miRNA (Zma-mir827-5p) and changes in the 









Nutrigenomics is the study of the effects of food and its elements on the expression of 
genes and how the nutritional environment is impacted by genetic variation. This area of science 
focuses on trying to understand the interaction between specific nutrients and bioactive 
components of food with genome, proteome, and metabolome to understand how specific 
nutrients or dietary regimes affect health (Mead, 2007). But despite many studies being done 
within this area, there is still not a clear understanding of exactly how some elements of food, 
like miRNAs, impact health. The ability of mammals to uptake exogenous miRNAs from food 
has been demonstrated (Zhang et al., 2012; Mu et al., 2014, Yang et al., 2015; Yang et al., 2016) 
with both plant-derived and mammalian derived miRNAs being found within the circulation.  
miRNAs are small non-coding nucleotide sequences that affect post-transcriptional gene 
regulation and RNA silencing (Zhang et al. 2012). Plant miRNA specifically affects this process 
through RNA cleavage and degradation (Taylor et al., 2014). 
The ability of mammals to uptake plant-derived miRNAs has been previously shown and 
suggests that plant miRNAs might be able to play a role in gene regulation within mammals, 
however, the exact mechanism of transfer and the levels needed within cells to have an impact is 
still debated (Chan et al., 2017).  Some plant miRNAs have been found to have targets within 
mammals (Zhang et al., 2012, Liu, Y. et. al, 2017), suggesting that diet may have a bigger impact 
upon animal health than was previously thought. More studies confirming the presence of plant 
miRNA in mammalian circulation and identification of more target sequences could hold the 
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possibility of novel treatments and a further understanding of the interaction between diet, 
insulin resistance, and obesity.  
Previous studies looking at dietary miRNAs have mostly been conducted with mice, pigs, 
and human subjects, with few studies using horses. This study was most interested in if feeding 
corn would result in the presence of a corn specific miRNA within horses. We hypothesized that 
plant miRNAs can be found within equine serum and skeletal muscle.  
MATERIALS AND METHODS 
Animal Care and Feeding Protocols 
All experiments were approved by the Colorado State University Institutional Animal 
Care and Use Committee. Twelve horses were used within this study: two were leased from 
Colorado State University and ten were already being used for another project being conducted 
at Colorado State University’s Equine Reproduction Lab (Fort Collins, CO). All twelve horses 
were kept in a dry lot with free-choice water and hay for a 21-day adjustment period before the 
feeding trial. The horses were all Quarter Horse type mares. Before the start of the 28-day 
feeding trial, the horses were randomly assigned to either the control group or the corn 
supplemented diet group. Before starting the feeding trial, all horses were weighed, and body 
condition scored. The horses were fed to meet the minimum nutritional requirements for 
maintenance and feeds were analyzed to determine nutritional composition. The horses were fed 
chopped hay and corn, if in the treatment group, once daily in the morning. The control group 
received 20 lbs. (9kg) /hd/d of chopped mixed alfalfa and grass hay daily, while the corn 
supplemented group received 20lbs (9kg) /hd/d of chopped mixed alfalfa and grass hay and 1lb 
(453 g)/hd/d of steam-flaked corn, these diets were not iso-energetic and both groups had access 
to round bales. Chemical analysis of feeds was performed to determine nutrient composition 
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(Appendix Table III). The horses on the corn supplemented diet were gradually acclimated to the 
diet over 8 days with individual feed bags being utilized to ensure each horse had the correct 
amount of corn offered to them at each feeding. On days 1-3 horses were fed ¼ lb. (113 g) of 
corn at each feeding, on days 4 and 5 the horses were moved up to ½ lb. (226g)  per feeding, 
days 6-7 consisted of ¾ lb. (340 g)  per feeding. Horses received the full 1 lb. (453 g) of corn 
from day 8 on.  
Serum and Tissues Collection 
Serum Collection 
10 mL serum separator blood tubes (Becton, Dickinson, and Company (BD), Franklin 
Lakes, NJ)  were used for all blood collections with two 10mL tubes collected at each time point. 
Blood was collected before the feeding trial began through jugular venipuncture and after 28 
days of supplementation at 0, 15, 30, 45, 60, 75, 90, 105, and 120 minutes after eating through 
intravenous catheters. One sample was also collected 360 minutes after feeding through jugular 
venipuncture. The intravenous catheters were placed aseptically and secured with a suture at the 
start of the 120-minute collection period, after each blood collection the lines were flushed with 
heparinized saline to avoid clotting within the catheter and clamped. Blood samples were then 
allowed to clot at room temperature for 30 minutes at a 45° angle before centrifugation for 10 
minutes at 2,000g to separate serum. The serum was separated off and placed into a 
polypropylene tube and stored at -80° C until RNA isolation. 
Muscle Biopsy collection  
Before starting (day 0)  and after the completion of the feeding trial (day 28), muscle 
biopsies were taken from the Gluteus medius muscle of the horse. Biopsies were taken from the 
left side of the horse before the feeding trial and from the right side at the end of the trial. The 
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biopsies were obtained by first shaving the hair off and scrubbing the site with betadine and 
alcohol before locally blocking the area through subcutaneous administration of lidocaine around 
the biopsy area. Once blocked using an aseptic technique a biopsy needle was inserted midway 
between the tuber coxae and ischiatic tuberosity to a depth of 6cm to obtain the tissue sample. 
Biopsy samples were placed into sterile cryotubes, then snap-frozen in liquid nitrogen before 
being stored at -80°C until RNA isolation. 
RNA Isolation from Serum 
RNA was isolated from equine serum using the manufacturer’s protocols for TRI 
Reagent® BD (Molecular Research Center, Inc. Cincinnati, OH). 500µl of serum was added to a 
tube along with 10µl Polyacryl carrier and 750 µl of TRI Reagent® BD. After samples were 
lysed using the TRI Reagent® BD, 200µL of chloroform was used to separate the RNA, DNA, 
and protein portions of the sample and allowed to sit at room temperature for 15 minutes before 
centrifuging the samples for ten minutes at 12,000g at 4⁰C. The RNA portion was then 
transferred to a new tube and precipitated with isopropanol and a Sodium acetate salt solution 
(pH 5.4). After RNA precipitation had occurred samples were centrifuged for 10 minutes at 
12,000g and the supernatant was pipetted off. The pellet was then washed with 1 mL of 75% 
ethanol. This washing procedure was repeated two more times, for a total of three ethanol 
washes per sample. The sample was then tested on a Nanodrop® Spectrophotometer ND-2000 
(Thermo Scientific, Wilmington, DE) to determine RNA concentration. If samples had a 
concentration higher than 150 ng/ µL of RNA they were treated with DNA-free DNase 
Treatment and Removal Reagent (Invitrogen/Life Sciences, Grand Island, NY) to remove 
genomic DNA then RNA purity was re-assessed. If RNA concentrations were below 150ng/µL 
then they were not subjected to the DNase treatment to ensure enough RNA was present for 
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adequate amounts of cDNA to be generated later. Samples were then stored at -80°c until the 
generation of cDNA through reverse transcription occurred. 
RNA isolation from Tissue 
RNA isolation from skeletal muscle was accomplished through grinding the samples with 
a mortar and pestle that had been previously washed with ethanol and nanopure water to ensure 
all contamination was removed. The mortar and pestle were then conditioned with liquid 
nitrogen and the muscle sample was placed into liquid nitrogen within the mortar and ground 
into a fine powder. The powder was then transferred to a clean tube and Trizol (Thermo 
Scientific, Wilmington, DE) was added according to the manufacturer’s protocols to lyse the 
cells within the sample. After lysing the sample 200µL of chloroform was used to separate the 
RNA, DNA, and protein portions of the sample and allowed to sit at room temperature for 15 
minutes before centrifuging the samples for ten minutes at 12,000g at 4⁰C. The RNA supernatant 
portion was then transferred to a new tube and precipitated with isopropanol. After RNA 
precipitation had occurred samples were centrifuged for 10 minutes at 12,000g and the 
supernatant was pipetted off. The pellet was then washed with 1 mL of 75% ethanol. This 
washing procedure was repeated two more times, for a total of three ethanol washes per sample. 
The sample was then tested on a Nanodrop® Spectrophotometer ND-2000 (Thermo Scientific, 
Wilmington, DE) to determine RNA concentration the samples were treated with a DNA-free 
DNase treatment and removal reagent to remove any genomic DNA, then RNA purity and 
concentration were re-examined. Samples were then stored at -80°c until the generation of cDNA 
through reverse transcription occurred. 
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Plant RNA Isolation 
RNA was isolated from the hay and corn samples using TRI reagent and the protocols 
produced by the manufacturer with some modifications. After the sample was homogenized 
using a mortar and pestle, previously cleaned with ethanol and nanopore water, and allowed to 
dry, it was combined with 750 µL of TRI reagent in a 1.75-ml tube and homogenized. Any 
extracellular material was removed through centrifugation at 12,000g for 10 minutes and the 
supernatant was transferred to a new tube for further preparation. As mentioned above, the RNA 
phase was separated using 200 µL chloroform. The RNA precipitation was conducted through 
the addition of 250 μL isopropanol and 25 μL salt precipitation solution. After precipitation 
occurred the sample was centrifuged for 10 minutes at 12,000g and washed with 75% ethanol, 
this step was repeated two more times. The sample was treated with a DNA-free DNase 
treatment and removal reagent to remove any genomic DNA and RNA purity assessed with a 
Nanodrop® Spectrophotometer ND-2000 (Santos et al., 2018). Samples were then stored at -
80°c until the generation of cDNA. 
Reverse Transcription 
cDNA was generated using the miScriptII RT kit (Qiagen Valencia, CA). 4µL 5x HiSpec 
Buffer and 2µL 10x Nucleics mix was used for the master mix for each reaction. Each tube 
contained 6µl of the master mix, enough RNA for 1000ng per reaction, and nuclease-free water, 
the total volume of each tube was 18µl. After mixing the reaction 2µL of Reverse transcriptase 
mix was added to the tube and the tube placed in a thermocycler. The reaction was incubated for 
60 minutes at 37°C, then at 95°C for 5 minutes. The cDNA was then diluted with 100µL of 
nanopure water for a total volume of 120 µL and a cDNA concentration of 500 pg/μL. The 
diluted cDNA was stored at -20⁰C until further use in real-time PCR.  
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Real-Time PCR Analysis 
Three mature plant miRNAs were selected for analysis due to previous reports of their 
expression in serum, or expression in the specific plant material feed (Xue et al., 2008; Zhang et 
al., 2009; Jiao et al., 2011; Zhang et al., 2012, Nulton, 2014) (Appendix table II). The first plant 
miRNA used was Ath-miR156a which was found to be conserved across alfalfa and corn and 
identified within equine tissue and serum previously, Zma-miR827-5p was found to only be in 
corn feed, and Osa-mir1866-3p was found to only be in rice (Nulton, 2014). The relative level of 
the chosen three mature plant miRNAs was assessed in total equine serum and skeletal muscle. 
Each real-time PCR reaction contained 6 µL of total reaction, including 3µL 2x QuantiTect 
SYBR Green PCR Master Mix, .60µL 10x miScript Universal reverse primer,1.15 µl of 
nuclease-free water, 0.25 µL of cDNA, and 1µl miRNA specific forward primer. Cycle 
conditions consisted of reaction initiation at 95°C for 15 minutes, followed by 45 cycles of 94°C 
for 15 seconds to denature, 55°C for 30 seconds to anneal, and 70°C for 30 seconds for 
extension. Plates were run in duplicate and miRNAs were considered present if they were 
present at cycle number <37 and confirmed with amplification curves and singular melt peaks 
(Santos et al., 2018). A negative RT control, non-template control, and positive RNU1 control 
were included on all plates. 
Statistical Analysis 
To determine if plant and corn specific miRNAs are present within equine serum and 
muscle, raw Ct values were normalized to RNU1 (appendix table II), a small RNA used as a 
reference gene within human serum studies (Sanders et. al, 2012) and had a standard deviation of 
less than 2.5 for all samples.  This normalized value was considered ΔCt. The 1/ΔCt values were 
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not normally distributed, so data were analyzed using the Kruskal-Wallis test and Dunn’s test in 
R version 3.5 statistical software with P ≤0.05 being considered significant.  
RESULTS 
Horses were weighed and body condition scored on days 0 and day 28. No time, 
treatment, or time by treatment effect was found (Table 1). 
Analysis of samples from corn and hay fed by QuantiTect qRT-PCR revealed that ath-
miR156a was present in all feeds. The rice miRNA (osa-miR1866-3p) was only detectable in the 
corn feed and the corn miRNA (zma-miR827-5p) as expected was only present in the corn feed 
(Table 2).  
Plant miRNAs (ath-miR156a, zma-miR827-5p, and osa-miR1866-3p) were detectable in 
total serum miRNA on day 0 and day 28. Ath-miR156a was found in all horses at every time no 
treatment, time, or time by treatment effect was found (figure 5). Zma-miR827-5p was detectable 
in horses in both groups with a treatment effect (P<.05) present and horses fed corn having 
overall higher serum levels of this miRNA, no time or time by treatment effect were found 
(Figure 6). Osa-miR1866-3p was found in all horses at every time, no treatment, time, or time by 
treatment effect existed (Figure 7). 
All three plant miRNAs (ath-miR156a, zma-miR827-5p, and osa-miR1866-3p) were 
detected in muscle samples within each group (figures 8,9, and 10). No treatment, time, or time 




Table 1: Horse Body Condition Score and Weight. Horses were weighed on a livestock scale on day 0 and day 28 
of the trial. All horses were body condition scored using the Henneke system on a scale of 1-9. Shown as group 
mean and SD 
Group Body Condition Score Bodyweight (kg) 
Corn Day 0 6.17±0.41 553.91±26.90 
Control Day 0 6.00±0.58 552.78±35.84 
Corn Day 28 6.17±0.61 582.11±43.50 
Control Day 28 6.08±0.74 567.07±33.07 
 
Table 2: Plant miRNA Expression Across Feeds. Levels of plant miRNAs were detected using qRT-PCR in the 
round bales, chopped hay, and corn fed to horses throughout the feed trial. 
miRNA RNA sample Ct 
Ath-miR156a Mixed Grass Hay Round Bale 33.3 
Ath-miR156a Chopped Mixed Grass Hay 34 
Ath-miR156a Steam Flaked Corn 26.3 
Zma-miR827-5p Mixed Grass Hay Round Bale Undetectable 
Zma-miR827-5p Chopped Mixed Grass Hay Undetectable 
Zma-miR827-5p Steam Flaked Corn 23.4 
Osa-mir1866-3P Mixed Grass Hay Round Bale Undetectable 
Osa-mir1866-3P Chopped Mixed Grass Hay Undetectable 




Figure 5: Level of Plant miRNA (ath-miR156a) in Serum Across Time. qRT-PCR was performed to determine 
levels of ath-miR156a in serum across all diets at day 0 and day 28.  No treatment, time, or time by treatment effect 
was found. Shown as group means with 95% CI. Data were normalized to RNU1. 
 
Figure 6: Level of Corn miRNA (zma-miR827-5p) in Serum Across Time. qRT-PCR was performed to 
determine levels of zma-mir 827-5p in serum across all diets at day 0 and day 28. A treatment effect for the corn 
group was found (P<.05). No time or time by treatment effect was found. Shown as group means with 95% CI. Data 
were normalized to RNU1. 
 
Figure 7: Level of osa-miR1866-3p in Serum. qRT-PCR was performed to determine levels of osa-mir1866-3p in 
serum across all diets at day 0 and day 28. No treatment, time, or time by treatment effect was found. Shown as 
group means with 95% CI. Data were normalized to RNU1. 
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Figure 8: Relative Level of Plant miRNA (ath-miR156a) in Muscle Across Time. qRT-PCR was performed to 
determine levels of ath-miR156a in muscle across all diets at day 0 and day 28. No treatment, time, or time by 
treatment effect was found Shown as group means with 95% CI. Data were normalized to RNU1. 
 
Figure 9: Level of Corn miRNA (zma-mir 827-5p) in Muscle Across time. qRT-PCR was performed to 
determine levels of zma-miR827- 5p in muscle across all diets at day 0 and day 28. No treatment, time, or time by 




Figure 10: Level of osa-miR1866-3p in Muscle. qRT-PCR was performed to determine levels of osa-miR1866-3p 
in muscle across all diets at day 0 and day 28. No treatment, time, or time by treatment effect was found. Shown as 
group means with 95% CI. Data were normalized to RNU1. 
 
DISCUSSION  
To determine if plant miRNAs can be absorbed from feedstuffs into serum, samples were 
collected on Day 0 and Day 28 of a feeding trial. Serum on day 28 was collected before feeding, 
15, 30, 45, 60, 75, 90, 105, 120 minutes, and 360 minutes after feeding corn to the corn group 
(CORN). The control group (CONT) was not fed hay at the start of the collection period on day 
28 but it is unknown when the last time the horses ate as they had access to hay in their pens 
before removing them for sample collections. The presence of plant miRNAs  (ath-miR156a, 
zma-miR827-5p, osa-miR866-3p) in total serum samples is similar to the results from previous 
studies on mice, humans, and calves (Zhang et.al, 2012, Wang et al, 2012), while different from 
others that did not find plant miRNAs in total serum within mice (Dickinson et al., 2013) and 
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horses (Nulton 2014).  In Nulton’s study, the only plant miRNA identified in equine serum was 
ath-miR156a and it was only found in exosomes (Nulton, 2014). The body of research that exists 
looking at the uptake of dietary miRNAs into circulation shows many are inconsistently picked 
up or detected in individual animals (Yang et. al, 2015), the wide variation in detectability of 
plant miRNAs within circulation could be due to re-uptake of the miRNAs into tissues, 
extremely low levels undetectable within cycle cutoffs, or individual variations in the absorption 
of intestinal contents, but further research needs to be conducted to better understand the process 
of dietary miRNA uptake and could illuminate the inconsistently present in current studies. The 
results revealed that ath-miR156a and osa-miR18663p were both detectable in total serum of all 
horses with no difference between treatment or time and no time by treatment effect existed. 
Although the corn miRNA (zma-miR827-5p) was present in both groups before corn was 
supplemented to horses a treatment effect was found where the level within the serum of CORN 
was higher than CONT (P<.05). The reason for the corn and rice miRNAs being present before 
supplementation is not clear as all horses were on a forage only diet for 14 days before taking 
day 0 samples and to our knowledge did not receive anything other than forage during this 
adjustment period; However, the horses were on the same premises and had intermittent access 
to the same pen system as horses receiving grain containing corn and rice bran for a different 
study looking at the effects of nutrition on oocytes (Catandi et al., 2020). The mares used within 
our study were also being teased and palpated up to two times a week for an unrelated study after 
palpation had been done in the stocks the mares were let out into a large pen that had access to 
the pens used by Catandi et al. to feed their horses if any feed had been left on the ground horses 
from our study could have eaten them. Catandi et al.’s study started before and extended beyond 
the end of our study. The horses were kept in an open-air pen and high winds do occur in the 
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geographical area where the study occurred, so although the corn was contained in feed bags and 
the horses were taken out of the community pen when being fed corn flakes could have been 
blown into the pen unnoticed and consumed.   
The corn miRNA (zma-miR827-5p) had the most variation in detection within the horses 
in total serum in this study, as horses did not have it appear in every time point, and the horses 
for which the miRNA was undetectable varied with time. Levels of this miRNA spiked 15 
minutes after ingestion of corn (figure 6), the earliest point at which ingested food can exit the 
equine stomach and enter the duodenum for further digestion and absorption of nutrients. This 
spike was not found to be statistically significant but suggests that miRNAs are taken into 
circulation within the early portion of the digestive tract, like the small intestine. The 
disappearance and reappearance of the miRNA could be the result of tissue uptake and then later 
release back into the circulatory system, however the exact details of miRNA uptake and release 
into circulation are not completely known. A study utilizing labeled miRNAs could help to 
provide more clarity on why miRNA concentrations in circulation vary with time. Within our 
study horses had access to water throughout the whole sample collection process, the intake of 
water holds the potential to dilute miRNA concentrations within serum and cause fluctuations in 
detectable levels as water is absorbed by the body.  Another reason for the appearance and 
disappearance of the miRNA in total serum maybe this specific miRNA may be more highly 
expressed within exosomes in serum, which were not tested in this particular study, or has a 
higher rate of degradation within the GI system of horses than the other two plant-based 
miRNAs tested. Zma-miR827-5p was selected to be used based upon previous studies showing it 
was expressed in corn (Zhang et. al. 2009, Jiao et. al, 2011) and that it was detectable in corn 
42 
despite cooking method, although steaming the corn did result in a large decrease in levels of this 
miRNA in another study (Lou et. al, 2017).  
All plant miRNAs (plant, corn, and rice) tested were detectable in equine muscle at Day 0 
and Day 28, no treatment, time, or time by treatment effect existed. The presence of plant 
miRNAs in tissue is in line with other studies that have found plant miRNAs to be taken up into 
mammalian tissues (Lou et. al, 2017, Zhang et. al 2012). Unlike Nulton’s study which only 
found ath-miR156a present in equine tissues regardless of diet (Nulton,2014), our study also 
identified zma-miR827-5p and osa-miR18663p in equine tissue in addition to ath-miR156a. As 
was previously mentioned another feeding study was being conducted at the same time as our 
study with some shared facilities, with groups being fed grain containing corn and rice bran, 
creating a potential source of contamination despite horses having very minimal access to 
facilities where feed could have been present for the horses within our study to consume 
(Catandi et al., 2020). As the effect of feeding corn on miRNA presence in horses was the main 
focus of this study we had a special interest in the potential presence of corn miRNA in muscle.  
As previously stated no treatment effect was found for the corn specific miRNA (zma-miR827-
5p) within muscle, this may indicate that a larger amount of corn should be fed to horses if future 
studies are conducted in this area and specific care should be taken to avoid environmental 
contamination should always be included. Currently, there is no information on the exact 
mechanism of how exogenous miRNAs within circulation become incorporated into cells within 
the body. This study did not take samples from smooth muscle cells within the  GI organs, the 
proximity of these cells to the intestinal lumen creates the possibility that these cells could have 
higher levels of plant-derived miRNAs within them and may show a notable difference sooner 
and with lower levels of supplementation compared to skeletal muscles.  Although zma-miR827-
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5p was found in both groups on Day 0 the corn supplemented group maintained roughly the 
same level on Day 28, while the control group (hay only diet) had a reduction in the relative 
level from Day 0 to Day 28 (Figure 9).  
The presence of osa-miR1866-3p  a rice miRNA (Nulton, 2014, Xue et.al, 2008.) in the 
corn feed sample could be a result of where the corn was obtained from, the corn used within the 
study was obtained from a pile stored in a covered open-air shed with Brewer’s grains in the next 
bay over, which can contain rice, the area where this shed is can get windy at times and the same 
front loader is used on all feed piles to load the feed truck. Osa-miR1866-3p, a rice specific 
miRNA, had a Ct value of 36, just barely inside of the cutoff window of <37 cycles that were 
used within this study, indicating very little was present within the corn feed. This however does 
not explain why the rice specific miRNA was detected in samples from both groups before and 
after the feeding trial, this particular miRNA did not have any treatment effects for muscle. 
The unexpected detection of corn and rice miRNAs (zma-miR827-5p and osa-miR1866-
3p, respectively) in both muscle and serum before supplementation could also be caused by the 
primer binding to an equine miRNA of a similar sequence, although the primers were created 
specifically for each plant miRNA, an oxidizing agent was not added to any of the samples. Plant 
miRNAs are structurally different than mammalian miRNAs as they contain a 2’-O-Me 
modification on the 3’ end which makes them resistant to oxidation. Due to their resistance to 
oxidation, an oxidizing agent like periodate can help to degrade mammalian miRNAs, but it will 
also degrade immature plant miRNAs as they do not have the same modifications as mature 
miRNAs (Huang et al., 2017). Previous studies looking for the uptake of dietary miRNAs also 
did not treat samples with periodate and subsequently, some plant miRNAs that have been 
identified in human plasma have been found to match human miRNAs (Witwer, 2018). We did 
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conduct a BLAST search on zma-miR827-5p and did not find any equine sequences that 
matched this miRNA sequence, however Lou et al. did a study where they feed fresh corn to 
pigs, and zma-miR827-5p was detected in serum and muscle before the addition of an oxidizing 
agent after which it disappeared suggesting that it may not have been a true plant miRNA or a 
non-mature variant that was detected (Lou et.al, 2017). The possibility of primer mismatch 
cannot be entirely ruled out, although the guidelines for annealing temperatures were followed 
and the primer sequences were taken from Nulton’s study which was also conducted on horses 
(Nulton, 2014). The continued debate over the uptake of dietary miRNA likely will continue 
until a gold standard method is adopted by all researchers to ensure identified miRNAs are true 
plant miRNAs.  
Our study did not investigate the potential interaction between plant miRNA and 
mammalian genes. Currently, the corn miRNA (zma-miR827-5p)  and rice miRNA (osa-
miR1866-3p) used within our study do not have any predicted mammalian target genes 
identified. A previous study identified four potential mammalian gene targets for ath-miR156a; 
ALG2, SUCLG2, HIF3A, and F11R (Nulton, 2014).  ALG2 is a member of the 
glycosyltransferase 1 family, glycosyltransferases are involved in the biosynthesis of 
polysaccharides, disaccharides, and monosaccharides, this gene is predicted to be repressed by 
ath-miR156a along with HIF3A, a gene related to hypoxia. Ath-miR156a is predicted to cleave 
SUCLG2, a succinyl-COA ligase,  and F11r, an adhesion protein (Nulton, 2014). In future 
studies predicted mammalian gene targets for the three plant miRNAs used within our study 
should be further explored to see if diet-derived miRNAs play a role in preventing or causing 
disease within hosts. 
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Our study shows that plant-derived miRNAs can be detected in equine serum and tissue 
after ingestion, but more studies within horses should be conducted to confirm these findings as 
the majority of studies looking at this phenomenon have been conducted in mice, pigs, and 
humans which are physiologically different than horses making comparisons between studies 
hard. The specific plant miRNAs used in this study are not heavily used by other research studies 
in this area, so direct comparison is not possible for many studies, however, the ability to uptake 
diet-derived miRNA likely is not impacted by the individual miRNA itself. Continued research 
into the mechanism by which diet-derived miRNAs exit the intestinal lumen and into circulation, 
either as free miRNAs or encapsulated in microvesicles such as exosomes could help to resolve 
the current debate within the scientific community. The ability of plant miRNAs to be absorbed 
into circulation and tissues and determining the levels required per cell to have an impact on 
mammalian gene regulation holds the potential for new therapeutic or diagnostic techniques to 
be developed within horses and other mammals.  
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CHAPTER III: THE EFFECT OF CORN SUPPLEMENTATION ON THE ENDOGENOUS 




The equine digestive system is evidence that through the course of evolution horses met 
their nutritional requirements through grazing, usually up to 16 hours a day. But due to the large 
role domesticated horses played as draft animals and the primary mode of transportation the diets 
of horses began to contain more grain to provide the animals with a concentrated source of 
energy to ensure they met the needs of their owners. Although not the primary source of 
transportation anymore, many horses today are fed some sort of grain concentrate. The variety of 
concentrate feeds that are available today is constantly growing, many of these feeds contain a 
concentrated form of energy in the form of cereal grains, like corn. Corn has a high energy 
concentration due to having a high non-structural carbohydrate (NSC) content, composed of 
starch and simple sugars. The combination of horses evolving to survive harsh winters and 
plentiful summers through the selection of thrifty genes, diets containing high levels of NSC, and 
many horses being confined to stalls with inadequate exercise has resulted in an increase of 
obesity within the equine population, often associated with insulin resistance and intolerance to 
glucose (Johnson et. al, 2012). Rapid ingestion of a large amount of NSC, like in the case of a 
horse getting into a grain bin, has also been associated with the onset of laminitis (Eades et. al, 
2014). The relationship between diet and metabolic disease is still not completely understood in 
many mammals and new studies are constantly being conducted.  
Diet has been shown to alter miRNA in previous studies with amino acids, carbohydrates, 
and fatty acids being linked to changes in miRNA expression  (García-Segura et al, 2013). As 
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incidences of equine obesity and metabolic diseases increase the role of diet on the body is 
becoming increasingly important. If diets can be designed to change miRNA profiles to prevent 
or treat a disease within mammals a whole new emphasis on the therapeutic uses of nutrition 
could develop.  The goal of this study is to compare levels of 277 endogenous equine miRNAs 
within horses on a forage only diet (CONT) to horses on a diet that includes corn 
supplementation (CORN). We hypothesize that feeding corn will result in a different profile of 
endogenous miRNAs within equine serum and skeletal muscle compared to horses on a forage 
only diet.  
MATERIALS AND METHODS 
Animal care and feeding protocols 
All experiments were approved by the Colorado State University Institutional Animal 
Care and Use Committee. Twelve horses were used within this study: two were leased from 
Colorado State University and ten were already being used for another project being conducted 
at Colorado State University’s Equine Reproduction Lab (Fort Collins, CO). All twelve horses 
were kept in a dry lot with free-choice water and hay for a 21-day adjustment period before the 
feeding trial. The horses were all Quarter Horse type mares. Before the start of the 28-day 
feeding trial, the horses were randomly assigned to either the control group or the corn 
supplemented diet group. Before starting the feeding trial, all horses were weighed, and body 
condition scored. The horses were fed to meet the minimum nutritional requirements for 
maintenance and feeds analyzed to determine nutritional composition. The horses were fed 
chopped hay and corn, if in the treatment group, once daily in the morning. The control group 
received 20 lbs. (9kg) /hd/d of chopped mixed alfalfa and grass hay daily, while the corn 
supplemented group received 20lbs (9kg) /hd/d of chopped mixed alfalfa and grass hay and 1lb 
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(453 g)/hd/d of steam-flaked corn, these diets were not iso-energetic and both groups had access 
to round bales. Chemical analysis of feeds was performed to determine nutrient composition 
(Appendix Table III). The horses on the corn supplemented diet were gradually acclimated to the 
diet over 8 days with individual feed bags being utilized to ensure each horse had the correct 
amount of corn offered to them at each feeding. On days 1-3 horses were fed ¼ lb. (113 g) of 
corn at each feeding, on days 4 and 5 the horses were moved up to ½ lb. (226g)  per feeding, 
days 6-7 consisted of ¾ lb. (340 g)  per feeding. Horses received the full 1 lb. (453 g) of corn 
from day 8 on.  
 
Serum and Tissue Collection 
Serum Collection 
10 mL serum separator blood tubes (Becton, Dickinson, and Company (BD), Franklin 
Lakes, NJ)  were used for all blood collections with two 10mL tubes collected at each time point. 
Blood was collected before the feeding trial began through jugular venipuncture and after 28 
days of supplementation at 0, 15, 30, 45, 60, 75, 90, 105, and 120 minutes after eating through 
intravenous catheters. One sample was also collected 360 minutes after feeding through jugular 
venipuncture. The intravenous catheters were placed aseptically and secured with a suture at the 
start of the 120-minute collection period, after each blood collection the lines were flushed with 
heparinized saline to avoid clotting within the catheter and clamped. Blood samples were then 
allowed to clot at room temperature for 30 minutes at a 45° angle before centrifugation for 10 
minutes at 2,000g to separate serum. The serum was separated off and placed into a 
polypropylene tube and stored at -80° C until RNA isolation. 
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Muscle Biopsy collection  
Before starting (day 0)  and after the completion of the feeding trial (day 28), muscle 
biopsies were taken from the Gluteus medius muscle of the horse. Biopsies were taken from the 
left side of the horse before the feeding trial and from the right side at the end of the trial. The 
biopsies were obtained by first shaving the hair off and scrubbing the site with betadine and 
alcohol before locally blocking the area through subcutaneous administration of lidocaine around 
the biopsy area. Once blocked using an aseptic technique a biopsy needle was inserted midway 
between the tuber coxae and ischiatic tuberosity to a depth of 6cm to obtain the tissue sample. 
Biopsy samples were placed into sterile cryotubes, then snap-frozen in liquid nitrogen before 
being stored at -80°C until RNA isolation. 
RNA Isolation from Serum 
RNA was isolated from equine serum using the manufacturer’s protocols for TRI 
Reagent® BD (Molecular Research Center, Inc. Cincinnati, OH). 500µl of serum was added to a 
tube along with 10µl Polyacryl carrier and 750 µl of TRI Reagent® BD. After samples were 
lysed using the TRI Reagent® BD, 200µL of chloroform was used to separate the RNA, DNA, 
and protein portions of the sample and allowed to sit at room temperature for 15 minutes before 
centrifuging the samples for ten minutes at 12,000g at 4⁰C. The RNA portion was then 
transferred to a new tube and precipitated with isopropanol and a Sodium acetate salt solution 
(pH 5.4). After RNA precipitation had occurred samples were centrifuged for 10 minutes at 
12,000g and the supernatant was pipetted off. The pellet was then washed with 1 mL of 75% 
ethanol. This washing procedure was repeated two more times, for a total of three ethanol 
washes per sample. The sample was then tested on a Nanodrop® Spectrophotometer ND-2000 
(Thermo Scientific, Wilmington, DE) to determine RNA concentration. If samples had a 
50 
concentration higher than 150 ng/ µL of RNA they were treated with DNA-free DNase 
Treatment and Removal Reagent (Invitrogen/Life Sciences, Grand Island, NY) to remove 
genomic DNA then RNA purity was re-assessed. If RNA concentrations were below 150ng/µL 
then they were not subjected to the DNase treatment to ensure enough RNA was present for 
adequate amounts of cDNA to be generated later. Samples were then stored at -80°c until the 
generation of cDNA through reverse transcription occurred. 
RNA isolation from Tissue 
RNA isolation from skeletal muscle was accomplished through grinding the samples with 
a mortar and pestle that had been previously washed with ethanol and nanopure water to ensure 
all contamination was removed. The mortar and pestle were then conditioned with liquid 
nitrogen and the muscle sample placed into liquid nitrogen within the mortar and ground into a 
fine powder. The powder was then transferred to a clean tube and Trizol (Thermo Scientific, 
Wilmington, DE) was added according to the manufacturer’s protocols to lyse the cells within 
the sample. After lysing the sample 200µL of chloroform was used to separate the RNA, DNA, 
and protein portions of the sample and allowed to sit at room temperature for 15 minutes before 
centrifuging the samples for ten minutes at 12,000g at 4⁰C. The RNA supernatant portion was 
then transferred to a new tube and precipitated with isopropanol. After RNA precipitation had 
occurred samples were centrifuged for 10 minutes at 12,000g and the supernatant was pipetted 
off. The pellet was then washed with 1 mL of 75% ethanol. This washing procedure was 
repeated two more times, for a total of three ethanol washes per sample. The sample was then 
tested on a Nanodrop® Spectrophotometer ND-2000 (Thermo Scientific, Wilmington, DE) to 
determine RNA concentration the samples were treated with a DNA-free DNase treatment and 
removal reagent to remove any genomic DNA, then RNA purity and concentration were re-
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examined. Samples were then stored at -80°c until the generation of cDNA through reverse 
transcription occurred. 
Reverse Transcription 
cDNA was generated using the miScriptII RT kit (QIAGEN). 4µL 5x HiSpec Buffer and 
2µL 10x Nucleics mix was used for the master mix for each reaction. Each tube contained 6µl of 
the master mix, enough RNA for 1000ng per reaction, and nuclease-free water, the total volume 
of each tube was 18µl. After mixing the reaction 2µL of Reverse transcriptase mix was added to 
the tube and the tube placed in a thermocycler. The reaction was incubated for 60 minutes at 
37°C, then at 95°C for 5 minutes. The cDNA was then diluted with 100µL of nanopure water for 
a total volume of 120 µL and a cDNA concentration of 500 pg/μL. The diluted cDNA was stored 
at -20⁰C until further use in real-time PCR.  
Real-Time PCR Analysis 
qRT-PCR was conducted using 277 endogenous equine miRNA primers (Appendix table 
I) previously used within this lab for other equine studies. qRT-PCR was performed on all 
muscle samples, day 0 serum, day 28 serum 1 and 6 hours after feeding, the choice to not test all 
serum samples was based on available supplies, funding, and time. Each real-time PCR reaction 
contained 6 µL of total reaction, including 3µL 2x QuantiTect SYBR Green PCR Master Mix, 
.60µL 10x miScript Universal reverse primer,1.28 µl of nuclease-free water, 0.12 µL of cDNA, 
and 1µl miRNA specific forward primer. Cycle conditions consisted of reaction initiation at 
95°C for 15 minutes, followed by 45 cycles of 94°C for 15 seconds to denature, 55°C for 30 
seconds to anneal, and 70°C for 30 seconds for extension. Plates will be run in duplicate and 
miRNAs will be considered present if they are present at cycle number <37 and confirmed with 
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amplification curves and singular melt peaks (Santos et al., 2018). A negative RT control, non-
template control, and positive RNU1 control were included on all plates. 
Statistical Analysis 
To determine the change in equine miRNA levels within serum between day 0 and day 
28 of the dietary treatments, raw Ct values were normalized to the geometric mean of 3 
endogenous controls (eca-mir376c, eca-mir14030, and ecamir770) that all had a standard 
deviation of less than 1.1 for all serum samples. The raw Ct values from the muscle samples 
were also normalized to the mean of 3 endogenous controls (eca-mir 15a, eca-mir6155p, eca-mir 
770) which had standard deviations of less than 2 amongst all muscle sample. Only miRNAs 
detected within all samples at all time points were used, 41 miRNAs in serum and 16 miRNAs in 
skeletal muscle fit these criteria and were used for statistical analysis. After normalizing all data 
this value was identified as ΔCt, the ΔCt for each gene on Day 0 was then used as the calibrator 
for calculating ΔΔCt (ΔΔCt=ΔCt-calibrator ) allowing each horse to act as its control. ΔΔCt was 
then used for further statistical analysis. Data were analyzed using a mixed model within the 
SAS statistical software, with P ≤0.05 being considered significant.   
RESULTS 
As stated in chapter II horses were weighed and body condition scored on days 0 and day 
28. No time, treatment, or time by treatment effect was found (Table 1). 
Analysis of equine serum found 12 of the 41  miRNAs chosen for statistical analysis, due 
to appearing in all horses at every time point, to have a significant treatment effect (P<.05) 
(figure 11 and table 3). 11 of the 12 miRNAs resulted in a significant downregulation of the gene 
within the CORN group compared to Day 0, while ecamir4903p had a significant upregulation 
within the CONT group compared to Day 0 (P<.05) (Table 3).  Analysis of eca-mir 129a5p 
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showed a time by treatment effect for CONT 1-hour post-feeding (P<.05), where it had 
significantly lower levels compared to CORN (figure 12). A time effect was found for eca-mir 
4865p for day 28 one after feeding (P<.05), both groups had a down-regulation of this miRNA at 
this time point compared to day 0. Although not a significant difference five of the 12 miRNAs 
that had a treatment effect  (eca-mir 4865p, eca-mir 598, eca-mir 195, eca-mir 192, eca-mir 
129a5p) had higher levels in CORN compared CONT on Day 28 at one-hour post-feeding. 
Analysis of equine skeletal muscle for 16 miRNAs found in all horses at every time point 
found three miRNAs (eca-mir 1515p, eca-mir 106b, and eca-mir 133a) to have a treatment effect 
post corn supplementation (P<.05) and 3 miRNAs (eca-mir 129a5p, eca-mir 191, eca-mir 10b)  
to have a trend towards a significant treatment effect (.1>P>.05) (Figure 13). No time or time by 
treatment effect was found. 
 
 
Figure 11: Difference between day 0 and day 28 Serum Sample Endogenous miRNAs Related to Obesity or 
Metabolic Disorders. qRT-PCR was performed to determine levels of endogenous miRNAs in serum across both 
diets at day 0 and day 28 1 hour and 6 hours post-feeding. Endogenous miRNAs associated with Obesity or 




baseline and Day 28 1-hour post-feeding and 6 hours post-feeding with 95% CI. *Eca-mir486-5p also had a time 
effect 1-hour post-feeding corn (P<.05). No time by treatment effect was found for these miRNAs. 
Table 3: Difference in Endogenous miRNAs within Serum from Day 0 to Day 28.  qRT-PCR was performed to 
determine levels of endogenous miRNAs in serum across both diets at day 0 and day 28 1 hour and 6 hours post-
feeding. Represented as the mean difference between baseline and Day 28 1-hour post-feeding and 6 hours post-
feeding with 95% CI. No time or time by treatment effect was found.  
  Day 28 1-hour post feeding Day 28 6-hours post feeding  








ecamir598   2.36±1.25 0.95±1.25 2.86±1.25 0.64±1.25 
ecamir326 5.39±3.40 0.04±3.40 4.78±3.40 2.67±3.40 
ecamir3715p 2.89±3.02 -1.42±3.02 2.21±3.02 0.64±3.02 
ecamir1271 2.74±2.32 -1.62±2.32 2.66±2.32 -2.51±2.32 
ecamir195 7.99±4.28 0.63±4.28 7.48±4.28 -0.98±4.28 
ecamir4903p -1.17±3.11 -5.26±3.11 -1.11±3.11 -4.69±3.11 
 
 
Figure 12:Effect of Corn Supplementation on Serum Endogenous miRNA eca-mir129a5p. qRT-PCR was 
performed to determine levels of endogenous miRNAs in serum across both diets at day 0 and day 28 1 hour and 6 




Represented as the mean difference between baseline and Day 28 1-hour post-feeding and 6 hours post-feeding with 
95% CI. No treatment or time effect was found. 
 
Figure 13:Effect of Corn Supplementation on Muscle Endogenous miRNAs. qRT-PCR was performed to 
determine levels of endogenous miRNAs in muscle across both diets at day 0 and day 28. Eca-mir1515p, -106b, and 
-133a had a significant treatment effect (P<.05). Represented as the mean difference between baseline and Day 28 
with 95% CI. No time effect or time by treatment effect was found. 
DISCUSSION 
To determine how diet impacts endogenous miRNAs half of the horses (n=6) in our study 
were supplemented with corn for 28 days with serum samples being taken pre and post 
supplementation for comparison. Of the 277 miRNAs analyzed by qRT-PCR, 41 were found to 
appear in every horse at every time point and used for statistical analysis. Twelve miRNAs were 
found to have a treatment effect of which six, eca-mir16, -4863p, -4865p, -126-3p, -296, and -
192, have been linked to obesity or metabolic disease (Figure 11). Meerson et al. found mir16-2-
3p and mir126-5p could be used distinguish early from complicated T2DM in individuals with 
77% accuracy, these two miRNAs are in the same family as mir16 and mir126-3p respectively 
suggesting that these families could serve as biomarkers for metabolic diseases involving similar 
*P<0.05 
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components as T2DM (Meerson et al., 2019). Mir 126-3p has also been found to be upregulated 
in patients with diabetic kidney disease (Assmann et al., 2018), have decreased levels in plasma 
and circulating angiogenic cells of patients with T2DM compared to healthy individuals, 
however amongst human subjects with T2DM those with a history of a major cardiac event had 
lower levels of mir126-3p, suggests it can serve as a biomarker for systemic inflammation and 
angiogenic status (Olivieri et al., 2015). Within our study we found the equine variant of mir126-
3p  to be downregulated and have lower levels on day 28 in CORN compared to CONT which 
could suggest based on Olivieri et al.’s study that a diet supplemented with corn increases the 
chances of horses developing metabolic disease. We found eca-mir4863p to be downregulated 
form D0 and at similar or lower levels in CORN compared to CONT, this is in contrast to 
Nulton’s study which found this miRNA to be increased in horses fed corn (Nulton 2014), in 
addition to previous studies the have found circulating  mir4863p in humans to be increased in 
T2DM patients and obese children (Meerson et al., 2019, Marzano et al., 2018, Prats-Puig et al., 
2013). Within our study we observed higher circulating levels of eca-mir4865p in CORN 
compared to CONT on day 28 1 hour post-feeding, there was not a significant difference in the 
level within circulation between the groups but this observation is notable as mir4865p has 
previously been found to be present in higher levels in circulation within humans studies looking 
at pre-pubescent obesity and males with metabolic syndrome (Prats-Puig et al., 2013, Zaki et al., 
2019). Compared to D0 both groups had downregulation of mir4865p at 1-hour post-feeding on 
day 28 explaining the time effect that was found and the treatment effect is illustrated by CORN 
having more downregulation of this miRNA than CONT(figure 11). The next miRNA in serum 
that was found to be impacted by corn supplementation was eca-mir296, studies conducted in 
humans have illustrated an association between mir296 and regulation of adipose tissue, with 
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higher concentrations being found in the visceral adipose tissue of obese individuals and 
amongst obese individuals, those with T2DM had lower expression (Gentile et al., 2018). 
Although the Gentile et al. study linking mir296 to the regulation of adipose tissue was looking 
at miRNA levels within tissue and did not investigate circulating miRNAs, it investigated both 
visceral and subcutaneous adipose tissue which would require some form of non-paracellular 
communication as these two tissues are found in different areas of the body, the circulatory 
system is often utilized in this process, suggesting the possibility that circulating levels of mir296 
could also differ, especially during adipogenesis. Another miRNA found within our study linked 
to obesity and related disorders was mir192, within our study we found the miRNA to be 
downregulated in CORN compared to Day 0; however, circulating levels of this miRNA in 
CORN on day 28 at 1 hour was higher than CONT a notable observation but a significant 
difference did not exist. Previous studies have illustrated the possibility of mir192 as a conserved 
biomarker for obesity and metabolic states as it was found to have increased levels in the 
circulation in both mice and humans suffering from obesity and metabolic disorders (Jones et al., 
2017. Ortega et al., 2013). Multiple studies have also found increased levels of mir-192 in 
exosomes of individuals with insulin resistance, suggesting it plays a role in the problem(Castano 
et al., 2018, Parrizas et al., 2015, Shah et al., 2017, Jones et al., 2017). Mir192-5p which is in the 
same family as mir192 has been found to regulate lipid synthesis in non-alcoholic fatty liver 
disease and to be downregulated in patients with diabetic-related kidney disease(Liu, X-L et al., 
2017, Assmann et al., 2018). The studies associating mir192 with obesity, metabolic disorders, 
insulin resistance, and a possible role in lipid synthesis suggest that mir192 should be included in 
future studies looking at these disorders across species.  
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When searching through previous studies to determine if miRNAs found to have a 
treatment effect related to obesity and related metabolic diseases which in horses have been 
associated with diets high in NSC, eca-mir326 was not found to have an impact directly on these 
conditions and so was not included in figure 11; However, mir326 has been linked to reduced 
inflammation in pulmonary fibrosis when upregulation occurs (Xu et al., 2019). The association 
between reduction of inflammation suggests mir326 plays a role in regulating at least one 
pathway of inflammation and could impact inflammation due to other causes throughout the 
body. Within our study, mir326 was downregulated significantly in CORN horses on day 28 and 
had a larger downregulation than CONT (table 3), also lower circulating levels were observed in 
CORN compared to CONT suggesting that CORN may have had the potential for higher levels 
of inflammation. As obesity is considered to be a chronic state of inflammation, future studies 
looking at levels of mir326 in obese individuals could identify an association between levels of 
mir326 and obesity.  
Obesity is not usually associated with Type 1 Diabetes mellitus (T1DM), which like 
T2DM causes high glucose concentrations in blood, but unlike T2DM where the high glucose is 
a result of insulin resistance in tissues preventing insulin-dependent glucose uptake form 
occurring T1DM is associated with a lack of insulin being produced by the beta-cells within the 
pancreas. A potential miRNA biomarker for T1DM has been identified in mir326, as it is 
downregulated in individuals with T1DM (Azhir et al., 2019, Garcia-Diaz et al., 2018). Type 1 
diabetes has been linked to an increased risk of heart disease usually characterized by cardiac 
hypertrophy, silencing mir-195, which was found in our study to be downregulated in CORN 
horses after supplementation  (table 3), has been shown to reduce myocardial hypertrophy, 
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improve coronary blood flow, and myocardial function in mice with diabetes, suggesting mir-
195 could serve as a novel therapy for diabetic heart diseases (Zheng et al., 2015). 
Eca-mir129a5p was observed to have higher levels on day 28 in  CORN compared to the 
CONT horses at 1-hour post-feeding, not a significant difference, and was upregulated compared 
to day 0 in CORN. It has been proposed that mir129a3p, which is in the same family as 
mir129a5p, plays a role in glucose and lipid metabolism (Pescador et al.,2013), and mir129a5p 
specifically been shown to regulate glycolysis and cell proliferation by targeting glucose 
transporters on gastric cancer cells causing reduced glucose uptake and consumption (Chen et 
al., 2018) demonstrating it can affect glucose utilization and could potentially also impact normal 
gastric cells. Eca-mir129a5p was found to have higher levels in circulation within insulin 
resistant horses compared to insulin-sensitive horses (Santos et al., 2018), we observed higher 
levels in CORN suggesting they may have been at a higher risk of developing insulin resistance 
as a result of corn supplementation, but as previously stated there was not a significant difference 
in levels between the groups (Santos et al., 2018). Further studies looking at if mir129a5p affects 
glucose utilization of normal cells and how it is impacted by a meal could provide more 
information on how diet and genes interact within the body. Within horses specifically more 
studies should be conducted within normal and insulin-resistant horses, potentially on a variety 
of diets, to see how this particular miRNA is impacted by diet. 
The impact of diet on overall health has been investigated in horses for many years, but 
only one other study has looked at how diet impacts equine endogenous miRNAs specifically. In 
Nulton’s study, three different diets were given: alfalfa diet, alfalfa and corn diet, and alfalfa and 
rice diet to investigate how endogenous miRNA profiles in serum would change within horses 
given the different diets (Nulton 2014). In our study, we wanted to further investigate how a diet 
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supplemented with corn impacts endogenous miRNAs in equine serum and muscle. Unlike 
Nulton’s study which took serum samples six hours post-feeding, we decided to take serum 
samples every fifteen minutes up to two hours post-feeding, we only analyzed D0 and D28 1 
hour and 6 hours post-feeding samples due to time and material constraints, but future studies 
could test the stored serum samples to create a better picture of how endogenous miRNAs within 
serum vary post-meal. Our study only looked at circulating levels of miRNAs in total serum and 
did not look at the profiles of circulating miRNAs in exosomes, the possibility exists that the 
profiles of miRNAs within exosomes differed from that of total serum. We did not find any 
members of the Let-7 miRNA family to be significantly impacted by corn supplementation even 
though previous studies have linked them to obesity and T2DM in humans (Gentile et al., 2018) 
and found lower levels in serum exosomes after horses were fed corn (Nulton, 2014). The Let-7 
family has been shown to have a strong association with glucose tolerance and insulin sensitivity 
(Rottiers and Näär, 2012)., the absence of any significant changes in these miRNAs could be 
attributed to the level of corn being fed to the horses. Within this study, horses were fed 1 lb. of 
steam flaked corn a day, whereas in Nulton’s study they received 2 lbs. of kibbled corn feed, 
composed of 80% corn and 20% wheat resulting in roughly 1.6 pounds of corn a day (Nulton, 
2014). The difference in feed processing and composition between our study and Nulton’s could 
have impacted the digestibility of the corn and how the nutrients were metabolized. Analysis of 
the steam flaked corn fed in our study found it contained 78.6 % starch and 1.5% simple sugars 
(Appendix Table III-A), the two main groups within non-structural carbohydrates, Nulton’s 
study does not appear to have analyzed the feed for these specific components making it 
impossible to compare these particular feed components between the studies to determine if the 
difference in serum results could be attributed to nutritional makeup of feeds. More studies 
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looking at the impact of diet on circulating miRNA profiles in horses should be conducted to 
create a better picture of the interaction between diet and the overall health of horses. 
After completion of evaluating skeletal muscle for 277 equine miRNAs was completed, 
16 miRNAs were found to consistently appear within the equine muscle, with some miRNAs 
usually expressed in muscle not appearing within our study. Due to the low number of miRNAs 
appearing in every horse at every time point some miRNAs that appeared in the majority of 
horses at all time points were included to reach the 16 total miRNAs that were used for statistical 
analysis. Muscle samples were the first to be evaluated with qRT-PCR and after all 24 samples 
(12 from D0 and 12 from D28) had been analyzed in duplicate for all 277 equine miRNAs and 1 
housekeeping gene it was discovered that the endogenous primers had only been diluted to 
100µM instead of the intended 10µM, this is extremely likely to have resulted in the small 
number of miRNAs meeting analysis criteria. The primers were properly diluted for all of the 
serum evaluations. We had intended to reanalyze the muscle samples after all serum evaluations 
were completed but a lack of some reagents, time, and funds prevented analysis to be 
reconducted on the muscle samples.  
Statistical analysis of the 16 miRNAs selected for appearing in most samples found  eca-
mir1515p, eca-mir106b, and eca-mir133a to have a significant treatment effect (P<.05), all of 
which have been linked to obesity or muscle insulin response.   Within our study eca-mir1515p 
was found to be significantly Downregulated in CORN compared to D0 and CONT, mir1515p is 
differently expressed in humans considered obese compared to normal individuals, suggesting 
expression of this miRNA either plays a role in the regulation of obesity or is regulated itself by 
the process involved in obesity (Arner et al., 2012). Skeletal muscle is the main tissue 
responsible for post-prandial glucose uptake and over 70% of insulin-dependent glucose uptake 
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from the blood. Skeletal muscle insulin resistance has been demonstrated in individuals with 
T2DM and plays a role in the development of cardiovascular diseases (Ferland-McCollough et 
al., 2010, Gallagher et al., 2010). Within insulin-resistant skeletal muscle, mir106b was found to 
be upregulated and contribute to the regulation of skeletal muscle glucose uptake (Zheng, L-F. et 
al., 2019). Regulation of glucose uptake by this miRNA is due to targeting genes coding for 
mitofusin-2 (Mfn2) and glucose transporter (GLUT)-4 resulting in reduced levels of these 
proteins, reduced insulin sensitivity, and increased blood glucose concentrations. (Zhang Y et al., 
2013, Zhang Y et al., 2017). The findings of our study that eca-mir106b was downregulated in 
CORN after supplementation and compared to CONT, suggests that the amount of corn 
supplemented did not cause the muscle group samples to begin to develop or develop insulin 
resistance. 
 Previous studies of muscle across species show higher levels of mir133a in muscle tissue 
compared to other tissues and have shown it plays a role in myogenesis and regeneration (Rao et 
al., 2006). Within skeletal muscle, mir133a plays an important role in mitochondrial biogenesis 
and was found to be downregulated in skeletal muscle with insulin resistance and samples from 
T2DM patients (Nie et al. 2016, Zheng, L-F. et al., 2019, Gallagher et al., 2010). Within our 
study we did find mir133a to be downregulated in skeletal muscle on D28 compared to D0 in 
CORN, however, this miRNA had a more significant downregulation in CONT  which is in 
contrast to the previously mentioned studies examining this miRNA (Figure 13). The error that 
occurred with the concentration of primer very likely resulted in fewer miRNAs being identified 
as having significant changes as too much primer can prevent detection of SYBER green, as a 
result, we decided to also look at miRNAs that had a trend for significance to determine if any 
had associations with obesity, insulin resistance, or associated diseases.  
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A trend toward a significant treatment effect was found for eca-mi10b, eca-mir129a5-, 
and eca-mir191 (.05<P<.1) within skeletal muscle. Mir10b was found to be downregulated in 
CORN compared to D0 while remaining close to the same in CONT, this miRNA has been 
linked to T2DM, with downregulation noted in muscle tissue of hyperglycemic mice (Herrera et 
al., 2010). As previously mentioned  mir129a5p has been shown to regulate glycolysis within 
gastric cancer cells causing reduced glucose uptake and consumption (Chen et al., 2018), within 
our study we found this miRNA to be downregulated within CORN after supplementation. 
Considering the other miRNAs examined like mir106b which suggests the muscle tissue sampled 
was not insulin resistant, it would make sense that a miRNA responsible for reduced glucose 
intake would be downregulated when horses are feeding a diet higher in readily available glucose 
in the form of NSCs. A review of previous studies did not show any association between mir191 
and obesity or related diseases. 
As previously mentioned the Let-7 miRNA family has been strongly associated with 
diabetes when found in circulation and adipose tissue. This family of miRNA is also well known 
to act as a regulator of glucose within skeletal muscle with glucose intolerance and increased fat 
resulting from widespread overexpression of let-7 ( Frost and Olson, 2011). No changes were 
identified within our study for let-7 within skeletal muscle samples, but future studies looking at 
how this family is specifically impacted by diet would be beneficial in aiding to evaluate them as 
potential biomarkers for early detection of glucose intolerance in horses and aid in early diet 
interventions. Our study is the first equine study to look at the impact of diet on skeletal muscle 
miRNA profiles, as Nulton did not analyze tissue samples for endogenous miRNAs.  
Our study illustrates that diet does have a role in regulating levels of endogenous 
miRNAs in circulation and skeletal muscle of horses. The differing results we found for miRNAs 
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related to obesity and insulin resistance within our study compared to other studies could be due 
to all horses used within the study having no known history of insulin resistance, obesity, or 
EMS, whereas many of the studies linking miRNAs to conditions like obesity, insulin resistance, 
and diabetes utilized individuals already diagnosed with these conditions. The differences in 
upregulation or downregulation between our study and others should not be dismissed, but the 
ability of the corn supplemented diet to cause changes in expression levels of these miRNAs 
should also be recognized as it suggests the possibility that long term consumption of this diet 
could lead to more dramatic changes in miRNA expression more closely resembling the other 
studies. It should also be noted that making comparisons between studies can be difficult as the 
physiology of horses differs from humans and mice, this could also contribute to differences in 
findings. Despite multiple studies evaluating miRNA expression in serum and skeletal muscle of 
diabetic and insulin-resistant individuals, there are not many studies indicating exactly how these 
miRNAs are regulated and expression of miRNAs within serum and muscle likely involves 
complex crossovers of various metabolic pathways. Additional studies need to be conducted to 
better determine the physiologic role of skeletal muscle and serum miRNA expression in insulin 
resistance and metabolic disorders like EMS in horses. Future studies utilizing various diets 
should also be conducted and could serve to better illustrate and make associations between diet 
and changes in miRNAs related to obesity and insulin resistance within horses.  
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CHAPTER IV: DISCUSSION AND CONCLUSIONS 
 
 
Based upon the results from the first objective of this study we can conclude that plant 
miRNAs can be absorbed, released into circulation, and taken up by muscle tissue in horses. 
These findings suggest the possibility of interspecies gene regulation. The ability of diet-derived 
miRNAs to be absorbed and identified within total serum and muscle tissue is a major step in the 
process of gaining a better understanding of the mechanisms involved in the uptake of diet-
derived miRNAs and the roles they may play in gene regulation within animals. Additionally, 
this study is one of the first to demonstrate the ability of diet to impact endogenous miRNAs in 
serum and the first to demonstrate the impact on endogenous miRNAs in muscle. The potential 
for miRNAs within serum and muscle to be used as biomarkers for the detection of disease and 
nutritional status of horses could allow for earlier and more cost-effective detection of disease. 
This study aimed to identify the presence of diet-derived plant miRNAs within equine serum and 
muscle and to examine the effect of a corn supplemented diet on profiles of endogenous 
miRNAs in circulation and muscle.  
These findings add support to the hypothesis that diet-derived plant miRNAs, including 
corn-based miRNAs, are absorbed from the digestive tract and hold the potential via translational 
repression of endogenous mRNAs to regulate endogenous gene expression.  Based on this study 
there is not enough evidence to suggest that the presence of the corn miRNA (zma-miR827-5p) 
would cause changes in gene expression as zma-miR827-5p does not currently have any 
mammalian gene targets identified. As mammalian gene targets are identified for more plant 
miRNAs they will share targets with endogenous miRNAs and could emerge as competitors for 
binding to the targets changing overall gene expression. Our study was able to illustrate how 
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circulating levels of diet-derived miRNAs varied after ingestion of food over two hours and 6 
hours after ingesting corn. The results showed levels of diet-derived miRNAs in the corn feed 
(zma-miR827-5p) spiked 15 minutes after feeding corn to horses then began to vary in their 
appearance, the levels of ath-156a and osa-mir1866-3p also varied thought out the sampling 
window but to a lesser degree. The variation in the detection of these miRNAs could be a result 
of uptake into tissue, dilution within circulation, or incorporation into exosomes. Our study was 
not able to illustrate any changes in levels of plant miRNAs within tissue of horses, this could be 
due to multiple factors including insufficient levels of corn supplemented, changes occurring in 
other tissues, and it is unknown how long plant miRNAs remain detectable in skeletal muscle. 
Additionally, differences in digestion/metabolism of animal models need to be investigated and 
better normalizers developed or identified to be used within horses. 
Examination of serum and muscle samples at day 28 revealed several miRNAs that were 
differentially expressed from day 0 after corn supplementation. 11 miRNAs were differentially 
expressed in the serum of the horses fed a diet supplemented with corn on day 28 compared to 
day 0. The majority of these miRNAs have previously been reported to be linked with obesity, 
diabetes, and insulin resistance. 1 miRNA was found to be upregulated significantly in the corn 
group compared to the control group 1-hour post-feeding and previously was reported to be 
higher in insulin-resistant horses in addition to playing a role in glucose metabolism. Three 
miRNAs were differentially expressed in muscle tissue of horses fed corn, all of which have 
previous reports of association with obesity, insulin resistance, or diabetes. The dysregulation of 
these miRNAs within serum and muscle suggests that diets high in sugar and starch, like corn, 
initiate changes in miRNA expression that could lead to insulin resistance and obesity, two major 
components of Equine Metabolic Syndrome. The findings of this study contribute to developing 
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a better understanding of the role diet has to play in the management of equine metabolic 
diseases. 
Finally, this data supports the belief that diet plays a major role in the expression of 
endogenous miRNAs and the potential for diet-derived miRNAs to regulate mRNA expression 
within mammals. Further research should be conducted to determine mechanisms by which diet-
derived miRNAs are taken up into circulation in tissues and if they have a functional impact on 
endogenous gene expression. More studies should also be conducted within horses to examine 
the interaction between diet and genes linked to metabolic diseases, as the frequency of these 
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Appendix Table I: 277 Equine miRNA primer sequences 
Mature miRNA ID  Target miRNA Mature Sequence  
eca-let-7a  ugagguaguagguuguauaguu  
eca-let-7c  ugagguaguagguuguaugguu  
eca-let-7d  agagguaguagguugcauaguu  
eca-let-7e  ugagguaggagguuguauaguu  
eca-let-7f  ugagguaguagauuguauaguu  
eca-let-7g  ugagguaguaguuuguacaguu  
eca-mir-7  uggaagacuagugauuuuguugu  
eca-mir-9a  ucuuugguuaucuagcuguauga  
eca-mir-10a  uacccuguagauccgaauuugug  
eca-mir-10b  uacccuguagaaccgaauuugug  
eca-mir-15a  uagcagcacauaaugguuugug  
eca-mir-15b  uagcagcacaucaugguuuaca  
eca-mir-16  uagcagcacguaaauauuggcg  
eca-mir-17  caaagugcuuacagugcagguag  
eca-mir-18b  uaaggugcaucuagugcaguuag  
eca-mir-19a  ugugcaaaucuaugcaaaacuga  
eca-mir-19b  ugugcaaaucuaugcaaaacuga  
eca-mir-20a  uaaagugcuuauagugcagguag  
eca-mir-20b  caaagugcucauagugcagguag  
eca-mir-21  uagcuuaucagacugauguuga  
eca-mir-22  aagcugccaguugaagaacugu  
eca-mir-23a  aucacauugccagggauuucc  
eca-mir-23b  aucacauugccagggauuacc  
eca-mir-24  uggcucaguucagcaggaacag  
eca-mir-25  cauugcacuugucucggucuga  
eca-mir-26a  uucaaguaauccaggauaggcu  
eca-mir-27a  uucacaguggcuaaguuccgc  
eca-mir-27b  uucacaguggcuaaguucugc  
eca-mir-283p  cacuagauugugagcuccugga  
eca-mir-285p  aaggagcucacagucuauugag  
eca-mir-29a  uagcaccaucugaaaucgguua  
eca-mir-29c  uagcaccauuugaaaucgguua  
eca-mir-30b  uguaaacauccuacacucagcu  
eca-mir-30c  uguaaacauccuacacucucagc  
eca-mir-30e   uguaaacauccuugacuggaag  
eca-mir-31  aggcaagaugcuggcauagcu  
eca-mir-32  uauugcacauuacuaaguugca  
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eca-mir-34  uggcagugucuuagcugguugu  
eca-mir-92a  uauugcacuugucccggccugu  
eca-mir-92b  uauugcacucgucccggccucc  
eca-mir-93  caaagugcuguucgugcagguag  
eca-mir-96  uuuggcacuagcacauuuuugcu  
eca-mir-98  ugagguaguaaguuguauuguu  
eca-mir-99a  aacccguagauccgaucuugug  
eca-mir-99b  cacccguagaaccgaccuugcg  
eca-mir-100  aacccguagauccgaacuugug  
eca-mir-101  uacaguacugugauaacugaa  
eca-mir-103  agcagcauuguacagggcuauga  
eca-mir-105  ucaaaugcucagacuccuguggu  
eca-mir-106a  caaagugcuuacagugcagguag  
eca-mir-106b  uaaagugcugacagugcagau  
eca-mir-107b  agcagcauuguacagggcuauca  
eca-mir-122  uggagugugacaaugguguuug  
eca-mir-125a5p  ucccugagacccuuuaaccuguga  
eca-mir-125b  ucccugagacccuaacuuguga  
eca-mir-1263p  ucguaccgugaguaauaaugcg  
eca-mir-127  ucggauccgucugagcuuggcu  
eca-mir-128  ucacagugaaccggucucuuu  
eca-mir-129a3p  aagcccuuaccccaaaaaguau  
eca-mir-129a5p  cuuuuugcggucugggcuugc  
eca-mir-132  uaacagucuacagccauggucg  
eca-mir-133a  uuugguccccuucaaccagcug  
eca-mir-133b  uuugguccccuucaaccagcua  
eca-mir-134  ugugacugguugaccagagggg  
eca-mir-135a  uauggcuuuuuauuccuauguga  
eca-mir-135b  uauggcuuuucauuccuauguga  
eca-mir-136  acuccauuuguuuugaugaugg  
eca-mir-137  uuauugcuuaagaauacgcguag  
eca-mir-138  agcugguguugugaaucaggccg  
eca-mir-1393p  ggagacgcggcccuguuggagu  
eca-mir-1395p  ucuacagugcacgugucuccag  
eca-mir-1403p  uaccacaggguagaaccacgg  
eca-mir-1405p  cagugguuuuacccuaugguag  
eca-mir-141  uaacacugucugguaaagaugg  
eca-mir-1423p  uguaguguuuccuacuuuaugga  
eca-mir-143  ugagaugaagcacuguagcuc  
eca-mir-144  uacaguauagaugauguacu  
eca-mir-145  guccaguuuucccaggaaucccu  
eca-mir-146a  ugagaacugaauuccauggguu  
eca-mir-146b3p  ugcccuagggacucaguucugg  
eca-mir-146b5p  ugagaacugaauuccauaggcu  
eca-mir-147b  gugugccgaaaugcuucugcua  
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eca-mir-148a  ucagugcacuacagaacuuugu  
eca-mir-148b3p  ucagugcaucacagaacuuugu  
eca-mir-149  ucuggcuccgugucuucacuccc  
eca-mir-150  ucucccaacccuuguaccagug  
eca-mir-1515p  ucgaggagcucacagucuagu  
eca-mir-153  uugcauagucacaaaagugauc  
eca-mir-154  uagguuauccguguugccuucg  
eca-mir-155  uuaaugcuaaucgugauaggggu  
eca-mir-181a  aacauucaacgcugucggugagu  
eca-mir-181b  aacauucauugcugucggugggu  
eca-mir-182  uuuggcaaugguagaacucacacug  
eca-mir-184  uggacggagaacugauaagggu  
eca-mir-186  caaagaauucuccuuuugggcu  
eca-mir-187  ucgugucuuguguugcagccgg  
eca-mir-1883p  cucccacaugcaggguuugca  
eca-mir-1885p  caucccuugcaugguggaggg  
eca-mir-190b  ugauauguuugauauuggguu  
eca-mir-191  caacggaaucccaaaagcagcug  
eca-mir-192  cugaccuaugaauugacagcc  
eca-mir-193a5p  ugggucuuugcgggcgagauga  
eca-mir-193b  aacuggcccacaaagucccgcu  
eca-mir-194  uguaacagcaacuccaugugga  
eca-mir-195  uagcagcacagaaauauuggc  
eca-mir-196a  uagguaguuucauguuguuggg  
eca-mir-196b  uagguaguuuccuguuguuggg  
eca-mir-197  uucaccaccuucuccacccagc  
eca-mir-199b3p  acaguagucugcacauugguua  
eca-mir-199b5p  cccaguguuuagacuaucuguuc  
eca-mir-200b  uaauacugccugguaaugauga  
eca-mir-200c  uaauacugccggguaaugaugga  
eca-mir-204b  uucccuuugucauccuaugccu  
eca-mir-205  uccuucauuccaccggagucug  
eca-mir-206  uggaauguaaggaagugugugg  
eca-mir-211  uucccuuugucauccuuugccu  
eca-mir-215  augaccuaugaauugacagac  
eca-mir-216a  uaaucucagcuggcaacuguga  
eca-mir-216b  aaaucucugcaggcaaauguga  
eca-mir-217  uacugcaucaggaacugauugga  
eca-mir-218  uugugcuugaucuaaccaugu  
eca-mir-221  agcuacauugucugcuggguuuc  
eca-mir-222  agcuacaucuggcuacugggu  
eca-mir-223  ugucaguuugucaaauacccca  
eca-mir-224  caagucacuagugguuccguu  
eca-mir-296  gaggguuggguggaggcuuucc  
eca-mir-301b3p  cagugcaaugauauugucaaagc  
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eca-mir-302a  uaagugcuuccauguuuuaguga  
eca-mir-302b  uaagugcuuccauguuuuaguag  
eca-mir-302c  uaagugcuuccauguuucagugg  
eca-mir-302d  uaagugcuuccauguuuuagugu  
eca-mir-3233p  cacauuacacggucgaccucu  
eca-mir-3235p  aggugguccguggcgcguucgc  
eca-mir-3245p  cgcauccccuagggcauuggugu  
eca-mir-326  ccucugggcccuuccuccagc  
eca-mir-330  ucucugggccugugucuuaggc  
eca-mir-331  gccccugggccuauccuagaa  
eca-mir-335  ucaagagcaauaacgaaaaaugu  
eca-mir-3373p  cuccuaugagaugccuuuccuc  
eca-mir-3375p  gaacggcuucauacaggagcu  
eca-mir-3383p  uccagcaucagugauuuuguug  
eca-mir-3385p  aacaauauccuggugcugagug  
eca-mir-3405p  uuauaaagcaaugagacugauu  
eca-mir-3423p  ucucacacagaaaucgcacccgu  
eca-mir-3455p  gcugacuccuaguccagugcuc  
eca-mir-346  ugucugcccgcaugccugccucu  
eca-mir-3613p  ucccccaggcgugauucugauuu  
eca-mir-3615p  uuaucagaaucuccagggguac  
eca-mir-3623p  aacacaccuauucaaggauuca  
eca-mir-3625p  aauccuuggaaccuaggugugagu  
eca-mir-3693p  aauaauacaugguugaucuuu  
eca-mir-3695p  agaucgaccgugucauauucgc  
eca-mir-370  gccugcugggguggaaccuggu  
eca-mir-3715p  acucaaacugugggggcacu  
eca-mir-374b  auauaauacaaccugcuaagug  
eca-mir-376c  aacauagaggaaauuccacgu  
eca-mir-378  acuggacuuggagucagaagg  
eca-mir-379  ugguagacuauggaacguagg  
eca-mir-380  uauguaauaugguccacgucuu  
eca-mir-381  uauacaagggcaagcucucugu  
eca-mir-382  gaaguuguucgugguggauucg  
eca-mir-383  agaucagaaggugauuguggcu  
eca-mir-4093p  gaauguugcucggugaaccccu  
eca-mir-4095p  agguuacccgagcaacuuugcau  
eca-mir-411  uaguagaccguauagcguacg  
eca-mir-412  uucaccugguccacuagccg  
eca-mir-421  ggccucauuaaauguuuguug  
eca-mir-4235p  ugaggggcagagagcgagacuuu  
eca-mir-424  cagcagcaauucauguuuugaa  
eca-mir-429  uaauacugucugguaaugccg  
eca-mir-431  ugucuugcaggccgucaugcagg  
eca-mir-432  ucuuggaguaggucauugggugg  
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eca-mir-433  aucaugaugggcuccucggugu  
eca-mir-448  uugcauauguaggaugucccau  
eca-mir-449a  uggcaguguauuguuagcuggu  
eca-mir-450b5p  uuuugcaauauguuccugaaua  
eca-mir-451  aaaccguuaccauuacuguguu  
eca-mir-454  uagugcaauauugcuuauagggu  
eca-mir-4853p  gucauacacggcucuccucucu  
eca-mir-4855p  agaggcuggccgugaugaauuc  
eca-mir-4863p  cggggcagcucaguacaggau  
eca-mir-4865p  uccuguacugagcugccccgag  
eca-mir-487b  aaucguacagggucauccacuu  
eca-mir-488  uugaaaggcuauuucuugguc  
eca-mir-489  gugacaucacauauacggcggc  
eca-mir-4903p  caaccuggaggacuccaugcug  
eca-mir-4905p  ccauggaucuccaggugggu  
eca-mir-4913p  cuuaugcaagauucccuucuac  
eca-mir-4915p  aguggggaacccuuccaugagg  
eca-mir-493b  ugaaggucuuccgugugccagg  
eca-mir-494  ugaaacauacacgggaaaccuc  
eca-mir-495  aaacaaacauggugcacuucuu  
eca-mir-497  cagcagcacacugugguuugu  
eca-mir-4993p  aacaucacagcaagucugugcu  
eca-mir-500  uaauccuugcuaccugggugaga  
eca-mir-501  auccuucgucccugggugaga  
eca-mir-5023p  aaugcaccugggcaaggauuca  
eca-mir-5025p  auccuugcuaucugggugcua  
eca-mir-503  uagcagcgggaacaguacugcag  
eca-mir-504  agacccuggucugcacucuauc  
eca-mir-505  cgucaacacuugcugguuuccu  
eca-mir-507  auuggcaccucuuagagugaa  
eca-mir-5083p  ugauugucaccuuuuggaguaga  
eca-mir-5085p  uacuccagagggugucauucaca  
eca-mir-5095p  uacugcagacaguggcaauca  
eca-mir-514  auugacaccucugugagugga  
eca-mir-5325p  caugccuugaguguaggaccgu  
eca-mir-541  uggugggcacagaauccagucu  
eca-mir-5423p  ugugacagauugauaacugaaa  
eca-mir-5425p  cucggggaucaucaugucacga  
eca-mir-544b  auucugcauuuuuaacaaguuc  
eca-mir-545  ucaacaaacauuuauugugugc  
eca-mir-551a  gcgacccacucuugguuucca  
eca-mir-551b  gcgacccauacuugguuucag  
eca-mir-5823p  uaaccgguugaacaacugaacc  
eca-mir-5905p  gagcuuauucauaaaaguacag  
eca-mir-592  uugugucaauaugcgaugaugu  
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eca-mir-598  uacgucaucguugucaucguca  
eca-mir-6155p  ggggguccccggugcucggauc  
eca-mir-6153p  uccgagccugggucucccucuc  
eca-mir-628a  augcugacauauuuacuagagg  
eca-mir-632  gugccuguuuccuguggga  
eca-mir-652  aauggcgccacuaggguugug  
eca-mir-656  aauauuauacagucaaccucu  
eca-mir-660  uacccauugcauaucggaguug  
eca-mir-664  uauucauuuaucuccuagccuaca  
eca-mir-670  gucccugaguguauguggugaa  
eca-mir-6715p  aggaagcccuggaggggcuggag  
eca-mir-6713p  uccgguucucagggcuccacc  
eca-mir-672  ugagguugguguacuguguguga  
eca-mir-6745p  ggugcucacuuguccuccu  
eca-mir-684  aguuuucccuucaauucag  
eca-mir-703  aaaaccuucagaaggaaagga  
eca-mir-761  gcagcagggugaaacugacaca  
eca-mir-763  ccagcugggaggaaccaguggc  
eca-mir-7673p  ucugcucauacuccaugguuccu  
eca-mir-7695p  ggagaccucuggguucugagcu  
eca-mir-7693p  cugggaucucgggggucuugguu  
eca-mir-769b  ggaaaccucuggguucugagcu  
eca-mir-770  agcaccacgugucugggccaug  
eca-mir-872  aagguuacuuguuaguucagg  
eca-mir-873  gcaggaacuugugagucuccu  
eca-mir-874  cugcccuggcccgagggaccga  
eca-mir-8765p  uggauuucuuugugaaucacca  
eca-mir-8855p  uccauuacacuacccugccucu  
eca-mir-1179  aagcauucuuucauugguugg  
eca-mir-1180  uuuccggcucgagugggugugu  
eca-mir-1185  agaggauacccuuuguauguu  
eca-mir-1193  uaggucacccguuugacuauc  
eca-mir-1197  uaggacacauggucuacuucu  
eca-mir-1244  gagugguugguuuguaugagaugguu  
eca-mir-1248  uccuucuuguauaagcacugugcuaaa  
eca-mir-1255b  cggauaagcaaagaaagugguu  
eca-mir-1261  guggauuaggcuuuggcuu  
eca-mir-1271  cuuggcaccucguaagcacuca  
eca-mir-1291a  uggcccugacugaagaccagcagu  
eca-mir-1291b  aggcccugaaucaagaccagcagu  
eca-mir-1296  uuagggcccuggcuccaucucc  
eca-mir-1298  uucauucggcuguccagaugua  
eca-mir-1301  uugcagcugccugggagugauuuc  
eca-mir-13021  uugggacauacuuauacuaaa  
eca-mir-1302b2  uugggacauacuuauacuaga  
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eca-mir-1302d4  uugggacauacuuaugcuaaa  
eca-mir-1302e7  uugggauauacuuauacuaaa  
eca-mir-1302c5  uugcgacauacuuauacuaaa  
eca-mir-1461  aucucuacggguaaguguguga  
eca-mir-1468  cuccguuugccuguuuugcug  
eca-mir-1839  aagguagauagaacaggucuug  
eca-mir-1898  aggucaagguucacaggggauc  
eca-mir-1905a  caccacgagcccuaccacgcgguag  
eca-mir-1905b  caccagccccacuacgcgguag  
eca-mir-1905c  caccaccagccccaccacgcgguag  
eca-mir-1912  uacccagagcgugcagugugaa  
 
Appendix Table II: Non-Equine miRNA Primer Sequences. A.) Mammalian B.) Plant 
A) 
Mature miRNA ID Target Mature miRNA Sequence 
RNU 1A CGACTGCATAATTTGTGGTAGTGG 
 
B) 
Mature miRNA ID  Target Mature miRNA Sequence  
ath-mir-156a  UGACAGAAGAGAGUGAGCAC  
zma-mir-827-5p  UUUGUUGGUGGUCAUUUAACC  
osa-mir-1866-3p  UGAAAUUCCUGUAAAAUUCUUG  
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Appendix Table III: Feed Analyses. Reported on a dry matter basis. A.) Steam Flaked corn B.) 
Hays 
A) 
Analysis Parameters Steam Flaked Corn 
DM (%) 86.4 
DE (Mcal/kg) 3.96 
CP (%) 7.5 
Estimated Lysine (%) 0.21 
ADF (%) 2.4 
NDF (%) 6.2 
WSC (%) 2.1 
ESC (%) 1.5 
Starch (%) 78.6 
NFC (%) 80.7 
Dry Matter (DM), Digestible Energy (DE), Crude Protein(CP), Acid Detergent Fiber(ADF), 




Analysis Parameters Round Bale Chopped Hay mixture 
DM (%) 93.4 90.6 
DE (Mcal/kg) 2.21 2.18 
CP (%) 7.2 17.2 
Estimated Lysine (%) 0.25 0.60 
Lignin (%) 3.1 5.0 
ADF (%) 35.2 34.5 
NDF (%) 58.3 52.5 
WSC (%) 14.0 8.7 
ESC (%) 5.9 7.1 
Starch (%) 0.9 0.4 
NFC (%) 24.5 17.7 
Crude Fat (%) 2.6 3.0 
Ash (%) 7.4 9.7 
Dry Matter (DM), Digestible Energy (DE), Crude Protein(CP), Acid Detergent Fiber(ADF), 





Appendix Table IV: Henneke Body Condition Score Chart 
Body Condition Score Description 
1 Poor Animal extremely emaciated; spinous 
processes, ribs, tailhead, tuber coxae, and 
ischia projecting prominently; the bone 
structure of withers, shoulders, and 
neck easily noticeable; no fatty tissue can be 
felt. 
2 Very Thin Animal emaciated; slight fat covering over 
base of spinous processes; 
transverse processes of lumbar vertebrae feel 
rounded; spinous process, ribs, tailhead, 
tuber coxae, and ischia  prominent; withers, 
shoulders, and neck structure 
faintly discernible. 
3 Thin Fat buildup about halfway on spinous 
processes; transverse processes cannot be 
felt; slight fat cover over ribs; spinous 
processes and ribs easily discernible; tailhead 
prominent, but individual vertebrae cannot be 
identified visually; tuber coxae 
appear rounded but easily discernible; tuber 
ischii not distinguishable; withers, 
shoulders and neck accentuated. 
4 Moderately Thin Slight ridge along the back; faint outline of 
ribs discernible; tailhead 
prominence depends on conformation, fat can 
be felt around it; tuber coxae not 
discernible; withers, shoulder, and neck not 
obviously thin. 
5 Moderate Back is flat (no crease or ridge); ribs not 
visually distinguishable but easily 
felt; fat around tailhead beginning to feel 
spongy; withers appear rounded over spinous 
processes; shoulder and neck blend smoothly 
into body. 
6 Moderately Fleshy May have slight crease down back; fat over 
ribs spongy; fat around 
tailhead soft; fat beginning to be deposited 
along the side of withers, behind shoulders 
and 
along the side of neck. 
7 Fleshy May have crease down back; individual ribs 
can be felt, but noticeable filling 
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between ribs with fat around tailhead soft; fat 
deposited along withers, behind shoulders, 
and along neck. 
8 Fat Crease down back; difficult to feel ribs; fat 
around tailhead very soft; area along 
withers filled with fat; area behind shoulder 
filled with fat; noticeable thickening of neck; 
fat deposited along inner thighs. 
9 Extremely fat Obvious crease down back; patchy fat 
appearing over ribs; bulging fat 
around tailhead, along withers, behind 
shoulders, and along neck; fat along inner 
thighs 
may rub together; flank filled with fat. 
Original Source: Henneke et. al, 1983. 
 
